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Abstract 
Health Information Technologies (HIT) play an important role in supporting decisions 
making, health care delivery, and management of health services.  In recent years, new 
technologies have emerged in this field, such as ePrescribing, Computerized Physician 
Order Entry (CPOE), Bar Code Medication Administration (BCMA), electronic 
Medication Administration Record (eMAR), Automated Drug Management Systems, 
etc. It is said that the development of these new technologies will be catalysed by the 
implementation of Electronic Health Record (EHR), systems that have begun to 
implement in many countries, including Belgium. 
Once introduced into Health Information Technologies (HIT), the aim of this project is, 
at first, to describe Electronic Health Record (EHR) systems and study its impact on the 
healthcare system, as well as its maturity. The scope of our study was Belgium even 
though we extended our analysis to European countries as well as North America 
where EHR systems are mature. Secondly, the purpose is to analyse how the 
digitalization of information by using these new technologies could impact and 
improve pharmaceutical supply chain in hospitals. Finally, based on the findings from 
our research, a roadmap for Electronic Health Records (EHRs) implementation in a 
hospital is presented. 
 
  
 5 
Chapter 1: Health Information and Communication Technology: 
Electronic Health Record Systems 
1. Introduction 
The aim of the first chapter is to introduce the concept of Electronic Health Records 
(EHR) systems, an application of Information and Communication Technologies (ICT) 
that has experienced a major growth in the healthcare sector in recent years, as well 
as describe its current state of maturity in Belgium.  
2. Health Information and Communication Technology  
The introduction of Information and Communication Technology (ICT) within the 
healthcare sector has become a tendency towards which many countries are 
endeavouring. That is due to ICT play an important role in the management of health 
services, in supporting decisions making and in health care delivery (Huvenne, 2012, 
pp. 20-23).  
In recent years, many countries have been taking innovative initiatives to improve its 
performance and productivity on the healthcare sector by taking advantages of ICT. 
What is meant by “innovation in healthcare” is   “those   changes   that   help  healthcare  
practitioners focus on the patient by helping healthcare professionals work smarter, 
faster,  better  and  core  cost  effectively” (Thakur et al., 2011, p. 564). In other words, 
enable patient-centred improvements and better work processes for healthcare 
professionals at the same time. 
 
The aim of this research and innovation in the sector is to increase the efficiency and 
effectiveness of healthcare systems in order to change for a better quality of 
healthcare at a lower cost. The author Pagliari et al. (2005) put those to  words  as  “the  
application of Information and Communication Technology (ICT) in healthcare has 
grown exponentially in the last 15 years, and its potential to improve effectiveness and 
efficiency has been recognized   by   governments   worldwide”. Nowadays, ICT in 
healthcare is often referred to as “health telematics”   or   “e-health” (Huvenne, 2012, 
p.21). That is why e-health can be broadly defined as the application of ICT to health 
and healthcare (Ryu, 2012, pp.159-160). 
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3. E-Health 
Definition of e-health 
There are many ways to define e-health, although unfortunately, as Fatehi (2012) 
mentioned, no single consensus, all-encompassing definition of e-health exist (Burgun, 
Quantin and Venut, 2013, p. 406). In this study there are two that are highlighted. 
 
The World Health Organisation (WHO) defines e-health  as  “the use of information and 
communication technologies (ICT) for health. In its broadest sense, eHealth is about 
improving the flow of information, through electronic means, to support the delivery of 
health services and the management of health systems” (WHO, 2012). 
 
The European Commission proposes another overview of the term. E-health 
represents "the overarching term for the range of tools based on information and 
communication technologies used to assist and enhance the prevention, diagnosis, 
treatment, monitoring, and management of health and lifestyle" (Andoulsi and Wilson, 
2013, p.170). 
 
Benefits of e-health 
Many benefits can be obtained by using e-health technology. It covers essential areas 
and functionalities, which are “the interaction between patients and health-service 
providers, institution-to-institution transmission of data, or peer-to-peer 
communication   between   patients   and/or   health   professionals” (European 
Commission, 2012). This way, e-health enables better practices for healthcare 
professionals while gives patients the opportunity to get more involved in their 
healthcare. The sector becomes more productive since efficiency and effectiveness is 
improved, what turns into a better quality delivery of healthcare system services.  
 
Nowadays, many countries around the world are taking advantage of e-health 
technology. For instance, Denmark is a country that has already implemented national 
ICT systems in the healthcare sector. As it is mentioned from the European 
Commission (2012),  “The  Danish   information  system   is  cited  by  several  studies   to  be  
the most efficient in the world, saving doctors on average 50 minutes per day usually 
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spent on administrative work”. The Danish Health Data Network focuses on a "national 
centralized computer database which allows access to electronic medical records 
information [...] and communication between different health professional groups" 
(Kierkegaard, 2011) as well as enables patients to "access all of their medical 
information including medical records and test results” (Kierkegaard, 2011). These 
streamlined services for patients and healthcare workers "have led to cumulative 
savings of $120 million a year” (European Commission, 2012). 
 
In this study, it is conducted a research of an e-health application that is currently 
being implemented in many countries: Electronic Health Record (EHR).  
3.1. Overview on e-health interest 
The scope of this section is to make a brief overview of the initiatives regarding e-
health that have been recently developed and deployed in Belgium, especially around 
Electronic Health Records. To meet this objective, it is interesting to make a review of 
the initiatives that the European Commission has been developing in the field of study 
for all the Member States of the European Union. This way makes it possible to analyse 
whether both institutions, the European Commission and the Belgian government, are 
following the same trajectory or strategy/roadmap in the sector.  
3.1.1. From the European Commission 
 “The  European  Commission  has  been  investing  in  e-health research for over 20 years” 
(European Commission, Information Society and Media Directorate General, 2011). It 
can be witnessed through the fact that, since the early 1990s, the European Union 
research   programmes   “have been   supporting   eHealth   (…)   co-financing research 
projects to the tune of €500  million” (Liikanen, 2004, p.4). 
 
Since  2004,  the  European  Commission  “has  been  developing  targeted  policy  initiatives  
aimed at fostering widespread adoption of eHealth technologies   across   the   EU” 
(European Commission et al., 2011). This tendency started with the development of 
the 2004 e-Health Action Plan (eHAP). In this publication, there are three main target 
areas aimed to “address   common   challenges   and   create   the   right   framework   to  
support e-health [to all the Member States of the European Union]; set up pilot actions 
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to jump start the delivery of e-health; and share  best  practices  and  measure  progress” 
(European Commission, 2012).  
In the communication from the European Commission to the Council, the European 
Parliament, the European Economic and Social Committee and the Committee of the 
Regions (2004), entitled "e-Health - making healthcare better for European citizens: An 
action plan for a European e-Health Area", are specified the actions proposed by the 
eHAP to achieve the main three target areas. These actions are outlined in the ANNEX I 
of the thesis. 
 
In 2011, the European Commission Information Society presented a report analysing 
European progress towards e-health   Strategies,   known   as   “European   countries   on  
their  journey  toward  national  eHealth  infrastructures”, where the 2004-eHAP progress 
was analysed as: 
“Significant progress on several key dimensions of the eHealth Action Plan 
of 2004 was achieved. The most noteworthy one has been the strongly 
increased commitment of national and regional health authorities to 
provide leadership to eHealth implementation efforts, underlined also by 
the remarkable growth in assessment and evaluation activities. Whereas in 
2006 only 5 Member States reported related intentions, in 2010 already a 
considerable majority of 21 states mentions such undertakings - this is the 
largest increase in attention of all topics surveyed. The scope and 
procedures used are very diverse, however. Furthermore, by now all 
countries surveyed have either established specific competence centres 
or/and have dedicated departments in ministries.” (Stroetmann et al., 
2011, p.55) 
After that, the European Commission  has  shown  a  desire  “to  exploit  the  full  potential  
of online health systems and services within European e-health   area” (European 
Commission, 2012) trough diverse projects, such as the flagship initiatives Digital 
Agenda for Europe and Innovation Union that were   launched  as  part  of   the  “Europe  
2020 – A   strategy   for   smart,   sustainable   and   inclusive   growth”. Both initiatives, 
launched in 2010, incorporate an important role on the field of e-health. On the one 
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hand, “the Digital Agenda for Europe includes a number of targeted eHealth actions 
and goals as part of a wider strategy towards sustainable healthcare and ICT-based 
support  for  dignified  and  independent  living” (European Commission et al., 2011). On 
the other hand, the Innovation Union strategy, “introduces   the   concept   of   a   pilot  
European Innovation Partnership on active and healthy ageing, which will be launched 
in  2011” (European Commission et al., 2011).  
 
In parallel, an update version of the 2004-eHAP took place. This, driven by Member 
States and supported by DG INFSO and SANCO, has been followed up by the creation 
of the eHealth Governance Initiative. Its  aim  is  “to  contribute  actively  to  the  shaping  of  
the eHealth political agenda at EU level, with specific   focus   on   interoperability” 
(European Commission et al., 2011). As a whole, summarizing, it is provided an 
opportunity  “to  consolidate  the  actions  which  have  been  addressed  to  date,  take  them  
a step further (…),   in   the   context of the EU 2020 Strategy, the Digital Agenda for 
Europe as well as Innovation  Union” (European Commission et al., 2011).  
 
The strategic e-health   applications   to   achieve   these   objectives   focus   on   “patient  
summaries and EHR systems, ePrescription services as well as telehealth solutions” 
(Stroetmann et al., 2011, p.19). The overall objective regarding EHRs, object of study of 
this thesis, is to establish these systems in a regional and national level in all the 
Member States of the European Union aiming at promoting their interoperability. This 
way, it is contributed “the   free   movement   of   patients,   health   professionals,   and  
services across Europe” (Kofler, 2011, p.1). Electronic Health Record systems can 
continuously: 
“monitor  patients’  health  in  real  time,  allowing  health  professionals  to  
keep an   eye   on   them   from   a   distance   (…)   can also make it easier for 
patients, providers, and data to cross borders: a vital matter for EU 
citizens who can travel, live, and work anywhere  in  the  EU’s  27  Member  
States.” (Kofler, 2011, p.1) 
 
To   sum  up,   it   is   an  undeniable   fact   that   Europe’s   interest  on e-Health has increased 
over last years. From now on, the implementation of EHRs in the Member States is 
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becoming a significant step to continue growing and achieving desired goals for a 
better quality of the healthcare system. 
3.1.2. In Belgium 
The European Commission commissioned studies in the Member States of the 
European Union to analyse their progress relative to the 2004-eHAP main priorities. 
Hence, it is provided a reliable framework to assess the general interest in e-health 
from the Member States as well as what have been done so far in these countries with 
regards to promoting e-health implementation (Stroetmann et al., 2011).  
 
According to the study,  
“Belgium  has  no  official  national  eHealth  strategy,  but  several  laws  and  
policy decisions have contributed to the shaping of the general 
developments towards eHealth   use   (…)   these laws and official 
documents do not mention nor refer to the EU eHealth Action Plan.” 
(Devlies et al., 2010, p.4)  
That is due to Belgium’s  initiatives  in  the  field  of  study  preceded  the  mentioned  action  
plan. However, the fact that they were not initiated together does not mean that they 
are not linked. 
 
Hereunder   it   is   provided   a   schematic   overlook   at   Belgium’s   initiatives   regarding e-
health.   
© empirica 2009 
Figure 1 Belgian documents policy related to e-health 
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Officially, Belgian governmental interest and actions concerning e-health started when 
Royal Decree installed a commission for "Norms related to telematics in support of the 
healthcare  sector”  in  1999.  Its  main  purpose  was  to  “advise  the  Minister  of  Health  on  
the electronic data exchange of patient related data, promote electronic exchange 
between the different actors in healthcare and promote the use of Electronic Health 
Record  by  healthcare  professionals” (Devlies et al., 2010, p.15). In 2004, the Federal 
government agreed on the creation of the BeHealth-platform. As a consequence, a 
new public organisation was created in 2008 called eHealth-platform, arising as an 
action  to  “support  the  national  health  policy (…)  [and]  optimise quality and continuity 
of care and patient safety, to favour administrative simplification for healthcare 
professionals” (Devlies et al., 2010, p.16). The platform took over the functions and 
tasks of the above-mentioned health telematics commission aiming at addressing and 
coordinating all issues related to ICT use in the healthcare system (Huvenne, 2012, 
p.27).   
As has been seen above, it is true that at the beginning both institutions the Belgian 
government and the European Commission were not following the same strategy as 
far as e-health field is concerned. Their roadmaps were not linked. However, nowadays 
they focus on the same overall objectives, as well as implementing same e-health 
applications, Electronic Health Records. As a consequence,   Belgium’s   government 
roadmap benefits European Commission’s  objective   to establish EHRs in all Member 
States of the European Union in order to promote their interoperability.  
3.2. E-health Stakeholders  
In the published “Strategic Management: A Stakeholder Approach”, R. Edward 
Freeman  defined  the  term  “stakeholder”   in  a  broad  strategic  sense  as  “any  group  or  
individual that can affect or is affected by the achievement of  a  corporation’s  purpose”  
(Freeman, 2010, p.32). The aim of this section is to provide a general overview of the 
main stakeholders involved in the e-health sector of a country from the literature 
reviewed. After a research on the main actors that come into play on the field, it has 
been possible to briefly categorise, on a broad scale, all actors involved into several 
groups. 
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Figure 2 E-Health Stakeholders 
At first, it is important to mention who is the responsible of e-health systems. It aims 
to support the research on the field and the identification, development, 
implementation and dissemination of new e-health applications for the most efficient 
preventive or therapeutic strategies (Daniel, 2014, p.438). “In  the  majority  of  countries 
responsibility   lies   largely   with   the  Ministry   of   Health.   In   others   (…),   responsibility   is  
more widespread across several  ministries  and/or  agencies” (Stroetmann  et al., 2011, 
p.9). By now,  
“more   than   a   dozen   countries   have   established   legal   entities   as specific 
consultative bodies or competent authorities under ministerial supervision. 
Their  role  is  to  develop,  oversee  and  monitor  the  country’s  strategic  goals,  
and/or implement and manage eHealth infrastructure and application 
projects” (Stroetmann  et al., 2011, p.9).  
 
Secondly, there are the financial institutions or sources behind the sector, which are 
financing the development and implementation of e-health infrastructures and 
applications. In  the  case  of  Europe,  “the primary sources of funding are government or 
quasi-public sources,   (…)  Considering   that   individual   service  providers  usually  do  not  
have   an   incentive   to   establish   such   infrastructures   for   all” (Stroetmann  et al., 2011, 
p.14). It is important to take into account that private and public insurance companies 
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or public technology or innovation agencies are involved in financing as well. Among 
the  international  sources  of  funding  that  exist,  “EC  RTD  project  co-financing as well as 
funding from European Structural and Regional Funds and the European Investment 
Bank” (Stroetmann  et al., 2011, p.14) also contribute. 
 
Thirdly, there are all healthcare providers,  which  means  “not  only  health  professional  
but all the staff employed in the health sector including nursing, care, and 
administrative  staff” (Liikanen, 2004, p.8). E-health  systems  can  “empower  managers  
by spreading best practices and helping to limit inefficient and inappropriate 
treatment” (Liikanen, 2004, p.9) by taking advantages from e-health “applications  that  
improve  the  services  they  offer  and  reduce  medical  risks” (Liikanen, 2004, p.12).  
 
Moreover, the industry and suppliers of the healthcare sector, such as the 
pharmaceutical sector, is a necessary stakeholder area of the sector (Huvenne, 2012, 
p.16).  
 
Furthermore, it is also important to mention the IT solution providers of the healthcare 
sector, bodies in charge of conception of IT structure that support e-Health and ensure 
interoperability. They aim to support organizations to address complex challenges, 
which include coordinate care, assume risks, the need to reduce costs and manage 
complex payment models.  
 
At last but not least, all citizens form a significant group of actors as well. Apart from 
receiving a better quality service thanks to the use and sharing of better practices that 
e-health applications provides,   “systems   such   as   these   are   giving   patients   more  
information about their condition and choices, so that can take more responsibility for 
healthcare   decisions” (Liikanen, 2004, p.12). Furthermore,   “e-Health opens new 
opportunities for people who live in remote areas with only limited healthcare 
services,   as   well   as   marginalised   groups” (Liikanen, 2004, p.12). This group also 
includes patient associations around  healthcare  system.  “Las asociaciones de pacientes 
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se   han   convertido   en   un   imprescindible   (…)   para   labrar   el   futuro   de   la   atención  
sanitaria”  (Fundación Salud 2000, 2009, p.2)1. 
 
According to what has been seen above, on a broad scale the group affected by the 
achievement of e-health objectives is the healthcare system of the country, which 
directly affects all citizens of the region.  
 
To conclude, it is important to take into account that “careful  planning,  organisational  
setup and stakeholder involvement are key success factors for eHealth (infrastructure) 
projects” (Stroetmann et al., 2011, p.9). It is needed an active cooperation between 
stakeholders, health authorities, professionals, consumers, industry, etc., to ensure a 
successful implementation of e-health applications and, this way, obtain beneficial 
objectives, thereby creating a win-win situation (Stroetmann et al., 2011, p.15).  
3.2.1. E-health Stakeholders in Belgium 
By following the mentioned groups of the main stakeholders that have been seen 
above, the purpose of this sub-section is to provide an overview of the main actors 
that are involved in the e-health field in Belgium. 
 
To begin with the determination of the first group of stakeholders defined above, the 
responsible of e-health system in Belgium, it is important to have a general overview 
of the organizational structure of the Belgian Health sector. For this reason, in the 
ANNEX II of this study, it is provided a schema showing the organization of the health 
system at the federal level and the level of federated entities, with the most important 
departments, agencies and advisory bodies. As well, it is included a brief explanation of 
their roles. According to it then, responsibilities of Belgian Health System are shared 
between the federal state and the communities. On the one hand, at a federal level, 
the main entities that come into play in this group of actors are both institutions: The 
FPS Social Security, which controls all legislation concerning the social security of 
citizens what is   specifically   needed   in   the   field   due   to   the   amount   of   patient’s                                                          
1 “Patient  associations  have  become  an  essential  (…)  to  shape  the  future  of  health  
care.” (free translation) 
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information that e-health applications works with, and The National Institute for 
Health and Disability Insurance (NIHDI). This entity, together with the consultative 
body Belgian Health Care Knowledge Centre (KCE), offers ICT support.  On the other 
hand, at a community level, the entity responsible of healthcare matters is the Flemish 
Agency for Care and Health for the Flemish Community, which is responsible for 
development, implementation and evaluation of policies concerning regional health 
and care responsibilities. For the French Community, it relays on the Directorate-
General of Health within the Ministry of the French Community, in charge with public 
health policies, and the Regional Health Observatory, set up in the Walloon region, 
which aims specifically to improve health in the region and to contribute to health 
information. For the German-speaking Community, health responsibilities relay on the 
Department of Cultural and Social Affairs of the Ministry of the German-speaking 
Community (Gerkens and Merkur, 2010, p.68).  
 
As far as financial institutions or sources is   concerned,   “alongside   the   Ministry   of  
Health, the National Health Insurance Institute is the main source of finance of 
initiatives  and  projects  stimulating  the  introduction  of  eHealth  in  general” (Devlies et 
al., 2010, p.34). Apart from   that,   “project   support   through EC Structural Funds”   is  
another main source of e-health funding in Belgium. 
In particular, the Ministry of Health   “pays   mostly   for   infrastructure   initiatives   and  
interoperability” (Devlies et al., 2010, p.34). Funds from the National Health Insurance 
Institute aims to work on the mentioned eHealth-platform, the last significant initiative 
that has been taken place on e-health   field.   Both   institutions,   together,   “hands   out  
subsidies  to  the  users  of  the  certified  EHR  systems” (Devlies et al., 2010, p.34). Finally, 
international   funding   through   EC   Structural   Funds   focuses   on   “supporting   the  
participation of Belgian industry and research organisations in European eHealth 
projects” (Devlies et al., 2010, p.34). 
 
Healthcare providers involve all the staff employed   in   the  health   sector   in  Belgium’s  
healthcare facilities. As has been mentioned above, this group of actors represents 
physicians, nurses, care and administrative staff. 
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Apart from that, industry and suppliers of the Belgian healthcare sector is a significant 
group  of  actors.  For  example,  “industry  and  pharmaceutical  sector  is  also  an  important  
stakeholder  area  of  the  Belgian  healthcare  sector.   It   is  represented  in  Belgium  (…)  by  
pharmaceutical companies and by community or hospital pharmacies, which distribute 
pharmaceutical  to  the  population.” (Huvenne, 2012, p.16) 
 
Regarding IT solution providers of the healthcare sector in Belgium, there are many 
groups providing integrated IT solutions to healthcare sectors such as AGFA 
HealthCare and Siemens as is specified on the Healthcare Belgium website. 
 
Finally, Belgian population represents citizens, which is the largest stakeholder group 
(Huvenne, 2012, p.19).  The population of Belgium take advantage of e-health systems, 
as their main goal is always a better care for patients. E-health also opens up the 
possibility to citizens to become more involved in their health care.  
4. Electronic Health Record (EHR) systems 
4.1. Introduction to Electronic Medical Record systems (EMR) and Electronic 
Patient Record (EPR) systems 
To understand in depth EHR definition, in the below sub-section, it is important to take 
into consideration the terms of Electronic Medical Record (EMR) and Electronic Patient 
Record (EPR). Sometimes, both concepts are commonly known under the same term. 
However, the following distinction can be made. 
 
On  the  one  hand,  Electronic  Medical  Record  (EMR)  is  defined  as  “the  electronic  record  
of  an  individual  in  a  physician’s  office  or  clinic [seen as a single organization], which is 
typically in one setting and is provider-centric” (Stroetmann et al., 2011, p.19). On the 
other, Electronic Patient Record (EPR) is known   as   “the   electronic   record   of   an  
individual in a hospital or health care facility, which is typically in   one   ‘organisation’  
and is facility-centric” (Stroetmann et al., 2011, p.19). EPRs are more patient-centric 
than EMRs and are managed, shared and controlled by the individuals.  
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In the context, one can also hear the term Patient Health Record (PHR), which is an 
electronic application trough which individuals can access, manage and share their 
health information. Is understood as an EPR but in this case the information collected 
can come from different healthcare providers and healthcare facilities (Tang et al., 
2006). 
4.2. Introduction to Electronic Prescription (ePrescription) 
According to the literature reviewed, the introduction of EMR systems within an 
organization is mainly accompanied by the use of Electronic Prescription 
(ePrescription) systems, or vice versa. This is also the case of EMRs implementation in 
Belgium (Deviles et al., 2010, pp. 19-22). 
 
EPrescriptions are the computerized version of traditional handwritten or paper-based 
charts, commonly referred as drug charts, where physicians prescribe patient’s  
treatment plan in terms of pharmaceuticals. They are supplied according to the 
formulation details on these prescriptions. Both the handwritten and the electronic 
version are the basis for pharmaceutical supply and pharmaceutical administration 
(Goundrey-Smith, 2013). 
 
Electronic prescribing aims at facilitating the prescription process, supply and 
administration of pharmaceuticals within a hospital. In comparison to the traditional 
prescribing, allows capture a full prescribing history for a patient in a transferable 
manner and opens up the opportunity to add decision support tools to assist the 
prescriber in medicine selection (Goundrey-Smith, 2013). 
 
EPrescriptions play an important role in the following chapter as their use may have a 
significant impact on pharmaceutical supply chain in a hospital. 
4.3. Introduction to Electronic Health Record systems (EHR) 
Up to now, in this study it has been emphasized the importance of the dissemination 
of Electronic Health Record (EHR) systems in the healthcare sector, application of e-
health that has been already started to be implemented in various countries 
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worldwide with the overall objective to contribute on the improving of the healthcare 
systems. 
 
The European Commission defines EHRs as “the   longitudinal electronic record of an 
individual that contains or virtually interlinks data in multiple EMRs and EPRs, which is 
to be shared and/or interoperable across healthcare settings (inter-institutional) and is 
patient-centric” (Goundrey-Smith, 2013). In other words, EHRs are a shared, integrated 
or interlinked virtual record of all patient’s clinical relevant health and medical data 
and/or information independent of when, where and by whom it was recorded. It can 
also be understood as a patient summary or an account of their various encounters 
with the health system from divers providers (Goundrey-Smith, 2013). 
 
Summarizing,   EMRs   are   understood   as   patient’s   records   managed   by   healthcare  
providers, while EPRs are patient's records managed by individuals, all of them stored 
and available from the healthcare facility. EHRs are understood as an interface of these 
systems, which at the same time are interrelated with other healthcare provider's 
systems. They are managed for healthcare professionals and electronically available 
from different healthcare institutions. 
 
 
 
 
 
 
 
4.3.1. Advantages and disadvantages of EHR systems 
Paper-based patient medical records are still in use in many countries. However, their 
computerized version is evolving via EMR and EPR as EHR systems. The aim of this 
section is to have a general overlook at the impact of implementing EHRs. 
 
EMR EPR 
Hospital1 
EMR EPR 
Hospital2 
EMR EPR 
Hospitaln 
Figure 3 Representation of an EHR network 
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As it is said in Medical Informatics: e-Health, Fundamentals and Applications (2013), 
the  digitalization  of  all  patient’s  information  and  records  into  EMRs and EPRs in order 
to shape EHRs networks, has significant advantages to take into account aimed to: - Facilitate the exchange of health information: the immediately availability, in 
real-time, of patient data from all components of the information system, is a 
huge  advantage  given  by  EHR.  “The  electronic data can be shared at large scale, 
beyond a single hospital, for instance at regional, national or international 
scales” (Cuggia, Avillach and Daniel, 2014, p. 68). - Data protection, security and traceability: “The   EHR provides better data 
traceability and the activities around the patient. All the actions of the users 
are  stored  (…).  Moreover,  each  data  entry is time stamped and signed.” (Cuggia 
et al., 2014, p. 68) - Facilitate decision support: EHRs work as   a   source   of   patient’s   information,  
which is especially useful for healthcare professionals when determining a 
patient treatment. Apart from that, there is the possibility to connect decision 
support systems to the EHRs, which “can help the physician by generating 
reminders and alerts (e.g. to detect drug adverse effects) or by suggesting, 
from the patient data, diagnosis or therapeutic strategy.”  (Cuggia et al., 2014, 
p. 68) - Allow secondary reuse of the patient data: Apart from being a source of 
patient’s  data   for  healthcare  professionals, EHRs systems are also a source of 
information for management, evaluation and research purposes. The 
secondary reuse of the data is easier by using EHR systems, compared to the 
paper-based version, due to computerized data. Consequently,  
“Data  extraction and statistical analysis can be carried out for studies 
or to provide indicators and dashboards for different domains, like 
for   instance   clinical   research   (…),   epidemiologic   survey   (…)   or  
evaluation  of  professional  practices  (…).” (Cuggia et al., 2014, p. 69) - Teach activities: EHR systems can serve as a tool for teaching and training 
students due to the fact that patient data can be extracted to create 
pedagogical resources.  
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Therefore, according to “Electronic Medical Records: A Practical Guide for Primary 
Care”, and summarizing, three imperatives are driving towards Electronic Health 
Records development and deployment: interoperability, usability and health 
coordination (Skolnik, 2011, p.129). 
 
Furthermore, various interviews have been done on the same publication to many 
physicians that have already started to use EHRs, that is, EMRs, aiming at providing 
first-hand experiences of the usage of these systems. According to their opinions, 
apart from the advantages that have been seen above, there are some disadvantages 
important to mention as far as EHRs implementation is concerned. 
First  of  all,  as  Dr.  David  Dipietro  mentioned,  “the  implementation process takes a few 
years” (Skolnik, 2011, p.17). He also pointed that during this   process   “you   actually  
increase your staff  as  well  as  your  overhead” (Skolnik, 2011, p.17) due to the amount 
of work that represents. However, after the implementation of the system, it should 
have the opposite effect due to the computerization and standardization of many 
activities. Moreover, Dr.  David  Dipietro  added,  “I  feel   like  I  am  doing  more  work  now  
that used to be done by the nursing staff” (Skolnik, 2011, p.18). The fact that with 
these systems all is computerized under standards results a work overload for 
physicians. As a consequence, many physicians complained that this fact is reflected 
on a decrease of the amount of patients they can visit per workday. For example, Dr. 
Jim  King  said  that  “Prior  to  EMR,  I  would  see  an  average  of  35-40 patients a day, now I 
see 30-35” (Skolnik, 2011, p.32). Regarding to patient interactions, EHRs have both 
positive and negative effects. On the one hand, according to Dr. David Dipietro, there 
is   a   loss  of   interaction  because  physicians   “get   so   caught  up  with   the computer and 
typing   (…)   that   patients   seem   to   be   not   happy  with   the   EMR” (Skolnik, 2011, p.18). 
However,  by  making  extra  efforts  “to  make  sure  it  didn’t  appear  that  I  was  just  a  data  
entry person and not their doctor [as Dr. Jim King said] patients seem to be very 
receptive   and   appreciative   of   EMR” (Skolnik, 2011, p.32). As Dr. Keith Sweigard 
emphasized,  it  is  important  to  keep  in  mind  that  “always,  the  ultimate  goal  is  improved 
care  for  our  patients” (Skolnik, 2011, p.36). 
At an educational level, Dr. Cesar Ducque Gomez specified that  
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“An additional concern for us as a residency training site includes impact 
on   the   residents’   graduate  medical   education/training;   they   often   get  
frustrated while trying to use the system, resulting in less time and 
energy for learning medicine, less interaction with their patients, and an 
overall sense of being rushed and distracted.” (Skolnik, 2011, p.26) 
Finally,  Dr.  Patrick  VanSchoyck  highlighted   that  “With  EMR   if   the  electricity  goes  out  
(…)  the  EMR  will  shut  off  and  you are faced with an office full of patients but no chart 
to  look  at” (Skolnik, 2011, p.22). This dependency on electricity is a serious drawback 
of EHRs. However, in the case of Belgium there are specified in its action plan the type 
of consumers that must retain their power of supply as a matter of priority (such as 
hospitals, emergency services, vital communication services). Therefore, electricity is 
ensured in hospitals in case of power shortage (Elia website, 2015).  
 
To conclude, the advantages of implementing Electronic Health Records are 
significantly beneficial, in the long term above all, for the healthcare system 
improvement despite their mentioned disadvantages. It is important to take into 
account that the main finality of investing in these e-health applications is to deliver a 
better quality service of health care to patients apart from, moreover, improving 
interoperability, usability and health coordination. However, aiming at progressing in 
the field, there is a necessity to focus on improving and solving the highlighted 
drawbacks as well. 
4.4. Development of EHR systems 
The aim of this section is to provide a general overview of the current state of 
Electronic Health Records implementation around the world. That is, having an idea of 
the countries that have already started their way to national EHRs deployment as well 
as its maturity in Belgium. 
4.4.1. Worldwide 
The deployment and implementation of Electronic Health Record systems in the 
healthcare sector is a strategy that, at present, is being followed by many countries 
around the world. To make a brief but clear explanation, in this section it is 
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distinguished between three groups: European initiatives, American Initiatives and 
Other International Initiatives (Staccini, 2012, pp. 326-337). 
 
 As far as European initiatives on EHRs is concerned, as has been mentioned above, 
reliable information is provided by the European Commission through studies, which 
last version dates from 2010, in 31 European countries regarding e-health. Aiming at 
following the strategies proposed by the European Commission, the majority of these 
countries are currently working on improving their healthcare system by  “establishing 
national/regional EHR   systems” (Stroetmann, 2011, p.1). European initiatives in the 
field have been taken place in many countries such as Austria, Belgium, Czech 
Republic, Denmark, Estonia, Finland, France, Germany, Iceland, Ireland, Italy, 
Lithuania, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom and 
Turkey. It is important to note that the current state of maturity of the implementation 
of a national information system in each country varies depending on the region of 
study. E-health initiatives regarding EHR systems range from very small to very large, 
from local or regional to national or international, although there are not yet many 
large-scale national e-health procedures in routine operation. To exemplify this reality, 
below there is presented two countries in a different stage of creation of a national 
EHRs network.  
On the first hand, and as has been mentioned above as "The Danish Information 
system is cited by several studies to be the most efficient in the world" (European 
Commission, 2012), Denmark is an advanced country when it comes to e-health 
development.  
"The Danish eHealth system has two characteristics, which make the 
country a frontrunner in the field compared to other EU member states: 
First, IT applications [such as EHR] in the field of health are already 
deeply rooted at a local or regional level. This means that mature 
systems are in place not only for communication between health 
professionals, but also for patient access and data management, which 
leads to a certain amount of trust into health technology. Second, 
Denmark has a long history of financing and developing new IT 
applications in governance and health." (Doupi et al., 2012, p.39)  
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Examples for this can be found in the deployment of Electronic Health Records, as the 
first plan called Action Plan for EHRs from 1996 was developed. It was the basis for 
subsequent policy papers for e-health, which, as a consequence, guided the present e-
health strategy. Nowadays, Denmark is currently shaping a national EHR system 
“based on shared standards being implemented in all Danish hospitals" (Doupi et al., 
2012, p.24). On the other hand, contrarily, there is the case of Lithuania. In 2009 an e-
health programme was presented which consists of a gradual development and 
deployment of EHR systems in the country. “There  are  Hospital   information  systems  
already  inplace  in  three  big  hospitals  (…)  [but]  Currently  one  of  the  major  problems  are  
the uncoordinated actions of separate healthcare institutions already having invested 
in  their  own  information  systems” (Kiskiene , 2010, p.20). 
 
Apart from these countries that have been already started their way to set up a 
nationwide Electronic Health Record system, other Member States such as Cyprus, 
Luxembourg, Poland, Portugal and Romania are planning to implement EHRs in the 
near future. Contrarily, countries as Bulgaria, Greece, Hungary, Latvia, Malta, Slovakia 
and Slovenia, have no projects planned already to progress in this field.  
 
Apart from the European initiatives, other projects regarding the e-health application 
of study are being deployed in other nations. As far as American initiatives is 
concerned, the main significant are the ones that take place in The United States of 
America and Canada, countries that have already initiated their way towards EHRs.  
 
Regarding other international initiatives, stand out the projects carried out in Australia 
and New-Zeland regarding health data sharing. 
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4.4.2. In Belgium 
The following illustration provides a schema of patient summary‘s   evolution   in  
Belgium.  
4.4.2.1. Traditional Health Records 
“In   order   to   control   health   expenditure,   the   Belgian   government  made   a   very   early  
choice of a better patient care coordination, organized around the General 
Practitioner” (Staccini, 2014, p.327). As a consequence, in 1999, the National Institute 
of Sickness and disablement Insurance, the Belgian social protection system, deployed 
a paper-based   health   record   called   “Dossier Médical Global”   (DMG). Lately, its 
electronic version was launched in  2003:  “Dossier  Médical  Informatisé”  (DMI) (Staccini, 
2014, p.327). 
4.4.2.2. Arrival and current state of EHRs 
“The  official  start  of  dealing  with  the  contents  of  electronic  medical  records  
was marked by the Law  on  “Social  Affairs”  in  1999,  empowering  the  king  to  
define minimal criteria to medical / healthcare software in order to be 
homologated  by  the  Ministry  of  Health” (Devlies et al., 2010, p.20).  
The Law defined a subsidy or bonus to be paid to healthcare professionals for using a 
labelled   EHR   system.   Since   2005,   “the   certification   criteria   for   quality   labelled   EHR  
systems for general practitioners require them to be able to export the SUMEHR 
patient  summary” (Devlies et al., 2010, p.20). 
© empirica 2009 
Figure 4 Patient summary in Belgium 
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The SUMEHR (Summarised Electronic Health Record) patient summary was defined in 
2004 as part of the BeHealth Platform. It is a template, structure or format for the 
arrangement of medical information, providing physicians with the set of a patient 
relevant medical data, a synthetic  picture  of  a  patient’s  medical  status (Huvenne, 2012, 
p.60). The list of SUMEHR contents can be found in the ANNEX III. 
After   that,   the   “Belgian   health   authorities   intend[ed] to make patient summaries 
nationally  available  by  offering  a  “virtually centralised”  medical  record” (Devlies et al., 
2010, p.20) through the project launched by the initiative of the 2008 eHealth-
platform, which provides a basic service called Reference Directory that is seen as a 
store of medical records. It consists basically on two layers, the creation of a 
“metahub”  and  five  “hubs”.  The  “metahub”  is  the  first  layer  of  information  and  refers  
to the regional or local network, and the second layer is so-called “hubs”,  where the 
available electronic medical record for a given patient can be found (Milieu Ltd and 
Time.lex, 2013). 
The distribution of  hospitals  within  the  various  “hubs”, shown in the figure below, was 
established in 2010 in the context of telematics protocols of the FPS Health. 
 
 
 
 
 
 
 
 
 
Figure 5 The five established "hubs" 
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Figure 6 Distribution of the "hubs"2 
Huvenne (2012) analysed the current state of EHRs implementation at a national level 
in Belgium and proposed a model for both e-health and EHRs implementation at a 
Federal level, based on an information compilation of various authors, organizations 
and interviewees. It consists on a model based on the following five phases:  
1. Preparation and promotion: Relates to the need to prepare the sector for the 
adoption of EHRs and its related aspects, which will lead to its implementation. 
Moreover, it also relates to the promotion of the changes that will need to take 
place within the different levels of the health sector. 
2. Selection: Relates to both the selection and integration of existing systems that 
will answer to the needs of the sector. 
3. Adoption: Refers to the moment when healthcare organizations start putting in 
place the efforts necessary so as to use EHRs to support their healthcare 
related activities.                                                         2Available at: https://www.ehealth.fgov.be/fr/prestataires-de-soins/services-en-ligne/hubs-metahub/en-savoir-plus  
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4. Exploitation: Refers to the moment from which the consecutive various aspects 
of EHRs (preparation level and environment and system development) have 
been accepted as the required answers by users and that their usage is 
propagated to the predefined user groups. 
5. Renewal/Reinvention: Aims at enabling implementation of EHRs to become 
dynamic. 
According to the study, Belgium can be seen as soon leaving the preparation and 
promotion phase to enter the selection phase. However, at a regional level, the 
Réseau Santé Wallon (RSW) hub, which was created before the eHealth platform 
existed incentivised by projects coming from the field and motivated by various field 
actors such as telematics associations and medical professional syndicates, can be said 
to have already reached the selection phase and entered the adoption one. The reason 
why the process of implementing and deploying EHRs, hand in hand with 
ePrescriptions, at a national level is so slow and the adoption of these systems has 
taken different rates in the different hubs is mainly related to two factors. On the one 
hand, the aspects related to security, privacy and confidentiality to both patients and 
medical professionals are objects of controversy as medical instances are not in 
agreement. Moreover, political tensions seem to exist between the Regional level hubs 
and the Federal eHealth-platform on the way to integrate regional and Federal 
initiatives. On the other hand, the role and the methods used by the 2008 eHealth-
platform are highly debated among institutions and medical professionals due to a lack 
of comprehension of the advantages linked to this service. Due to a low involvement 
of stakeholders in the processes, there is a lack of acceptance of the infrastructure and 
info-structure solutions proposed by the governmental institution.  
 
According   to   the   latest   study  provided  by   the   European  Commission   “Country   Brief:  
Belgium”   in   2010   regarding   e-health   strategies   “there   is   now   a   good   coverage   of  
certified EHR systems throughout Belgium (>80% of all GPs)”   (Deviles   et   al.,   2010,  
p.20). Further key challenges would be to extend the scope of the accessible data, 
harmonise the EHRs standards, keeping them updated, as well as encourage health 
professionals  to  make  increased  use  of  the  records.  “Especially  the  take-up in hospitals 
is still on a lower level than with general practitioners, although this has begun to 
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change in recent years” (Deviles et al., 2010, p.21). In this way, wider goals could be 
achieved.  
4.4.2.3. Barriers of implementation  
The adoption of Electronic Health Records present barriers of implementation 
important to take into account: 
- Usability: These barriers of adoption are caused due to the complexity of the 
usage of such systems (multidisciplinary of screens, options and navigational 
aid). Perhaps, many practices and hospitals may not have the extra time 
required to learn how to work with a new system (Meinert, 2005).  
- Structural: Structural barriers are predominantly related to the structure of a 
country’s   health   care   system.   Consequently,   they   can   significantly   vary   from  
country to country. As far as EHRs is concerned, there are multiples systems 
and multiple vendors, which constitute a barrier to EHRs adoption and 
particularly to the connectivity with other systems that add significant benefit 
for   the   physician.   In   the   case   of   Belgium,   “doctors   are   independent  
practitioners who are paid by the patient who is then reimbursed by the health 
insurers. The fact that there is no direct contract and payment relationship 
between the health insurer and the doctor constitutes an interesting challenge 
for  implementation  of  EHRs  and  interconnectivity.” (Meinert, 2005) 
- Time: The introduction of electronic records in any practice will slow a 
physician’s  workflow,   as   it   results   in   additional   time  being   required   to   select,  
implement and learn how to use these systems (Meinert, 2005). 
- Privacy, confidentiality and security concerns: Healthcare providers and 
patients have voiced concerns around medical privacy with EHR systems. 
Although paper-based records can get lost or being viewed by unauthorized 
personnel, electronic records may be exposed to security breaches as threats. 
"The common privacy concerns with EHRs are unauthorized access to records, 
tampering with records and the risk of losing information due to a natural 
disaster" (University Alliance, 2014).  
In the case of Belgium, Legal and regulatory facilitators is provided in the 
ANNEX IV aiming at shaping a framework on privacy and confidentiality, liability 
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and data-protection. More   information   can   be   found   on   “Overview   of   the  
national laws on electronic health records in the EU Member States: National 
Report  for  Belgium”  report. 
- Cost: Finding the capital to invest in the infrastructure, personnel, training and 
support required to deploy and maintain an EHR system can be a barrier, as it 
can lead to result expensive. Furthermore, it is also influential the uncertainty 
over the long-term return on investment (University Alliance, 2014). 
- People: Healthcare organization may have to deal with healthcare providers 
and patients resistance to change. Both sides can get easily discouraged by the 
challenges and limitations exposed above. Moreover, as it is shown in 
Electronic Medical Records: A Practical Guide for Primary Care where there is 
provided some point of view of Electronic Health Records implementation in 
many practices, a significant barrier important to mention is the feeling from 
both, patients and healthcare providers, of losing interaction between them by 
the introduction of such technologies.  
In the particular case of Belgium, there are also added the barriers of adoption 
related to security, privacy, confidentiality and politics, as well as the lack of 
involvement of stakeholders in the project of implementing these systems, which 
have been mentioned in the previous sub-section.  
To sum up, in the sort-term the barriers of adoption can have a negative impact on 
both the productivity and financial performance. The main reason is the increment 
of  physician’s  time  spent  in  administrative  tasks,  what  can  turn  into  a  reduction  of  
the number of visits to patients per day during the process of implementation. 
Through a strategic plan for implementing such technologies, which should include 
a solid project timeline and a plan for communication and training, EHRs can prove 
their worth. However, the implementation of EHR systems has to be seen as a 
long-term investment in terms of usability, interoperability, health coordination 
and financial performance. 
  
 30 
5. Conclusion 
For the last years, there has been a global trend towards the development, 
deployment and implementation of Information and Communication Technology (ICT) 
applications in the field of the healthcare, also known as e-health. The aim of this fact 
is to increase the productivity of healthcare systems, in terms of efficiency and 
efficacy, meanwhile delivering a high-quality health care at a lower cost. This latter 
requirement has been a noteworthy restriction during the recent years due to the 
global economic and financial crisis. 
Electronic Health Record (EHR) systems are a digital collection to store and process 
health information about individual patients or population aiming, in the first place, at 
interchanging clinical information among healthcare providers to improve the quality 
of healthcare services. The imperatives that are driving such improvements are 
interoperability, usability and health coordination, covering the need of all engaged 
parties, the stakeholders of the healthcare sector (policy makers, financial institutions 
or sources, industry and suppliers from the sector, all citizens or patients, healthcare 
providers and IT solutions providers). As has been seen in the study, despite the 
difficulties to implement such technologies in the different practices, the benefits that 
an area, region or country can obtain from the deployment of EHRs systems are 
numerous and added value.  
In Belgium, with the launch of the e-Health Platform in 2008 after diverse initiatives in 
the field, the Belgian Government presented a path to improve their healthcare 
system at a national level in the field of e-health. That is through the creation of the 
national EHRs network with the so-called   “hubs”   and   “metahubs”   distributions.  
However, as has been seen, on the one hand the development of this process is still at 
an early stage due to problems and disagreements related to privacy, security and 
confidentiality of the systems as well as politic tensions between the Regional and the 
Federal level. On the other, there is a lack of involvement of stakeholders in the 
project of implementing EHRs systems. 
It is said that by creating national electronic records systems, broader benefits can be 
achieved at a healthcare facility, regional, national and even international level in 
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terms of medical mobility. The exchange of best practices and the latest research 
findings, interoperability and research and development would be facilitated. 
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Chapter 2: Impact of EHRs and ePrescriptions in hospital 
pharmaceutical supply chain 
1. Introduction 
The objective of this chapter is to analyse how Electronic Health Record (EHR) 
technologies, by using Electronic Prescriptions, may impact and improve 
Pharmaceutical Supply Chain in hospitals. To meet this objective, starting with an 
introduction to hospital logistics, an analysis of pharmaceutical supply chain in hospital 
is provided. That is, a study of techniques used for inventory management as well as 
inventory control through the hospital. Then, it is used the  Porter’s  model  to   identify  
activities involved in pharmaceutical supply chain that generate value for care, aim of a 
hospital. Finally, an analysis regarding how the implementation of Electronic Health 
Records (EHRs), by using Electronic Prescriptions (ePrescriptions), may improve or add 
value to the logistic chain of a hospital is presented. 
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2. Hospital Logistics 
This section aims at having a general understanding of Hospital Logistics, describing 
the main activities and the different flows that take place within a hospital. 
2.1. Introduction to Hospital Logistics 
Hospital Logistics can be defined as a set of design, planning and implementation for 
the purchase, inventory management and replenishment of goods and services 
surrounding the provision of medical services to patients (Landry and Beaulieu, 2001). 
The objective is to maximize output or throughput under the resources constraints, 
taking   into   accounts   the   different   actors’   requirements   for   delivery   flexibility   and  
reliability and acceptable medical outcome (Di Martinelly, 2008). 
 
In   1994,   Chow   and   Heaver   leaded   the   study   “Logistics   in   the   Canadian   health   care  
industry”,  which   provides   an   analysis   of   the   impact   of   logistics   in   the   structure   of   a  
hospital (which can be found in the ANNEX V). They came up to the conclusion that all 
activities that take place in a healthcare facility have its involvement in logistic costs, 
which  represents  a  46%  of  the  hospital’s  budget.   
 
As  logistical  costs  make  up  a  significant  part  of  hospital’s  annual  budget,  many studies 
have been done in order to optimize logistic activities, aiming at increasing efficiency 
and flexibility of organizations. Furthermore, lately logistics have gained much 
attention due to the fact that hospitals are under budget pressure as a consequence of 
the global crisis.  
2.2. Main Logistic Activities in a hospital 
According to Chow and Heaver (1994), the running of a hospital can be outlined by a 
number of core activities where all internal processes therein are held. Different actors 
with different goals are implied in these activities. 
 
The primary activity is the care and cure of the patients. Therefore, human and 
material resources, medical tests and clinical processes (diagnoses, interventions and 
medications) aim at addressing the main activity of the organization. The following 
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figure indicates the basic activities that take place in a hospital, adding their 
description below. 
 
 
 
 
 
 
 
 
 
- Internal Logistics: Groups the activities of purchasing, receiving, storage and 
distribution of products used on internal processes of the hospital. - Demand Management: Consist on analysing, planning and assigning the 
necessary resources in order to acquire the goods and services.  - Operational Services: Includes internal processes and activities that support the 
patient’s  stay  in  the  hospital. - External Logistics: It is associated with activities of medical monitoring of the 
patient. - Auxiliary Services: Groups other activities taking place within the hospital, such 
as catering services, shopping, religious services and others. 
Although no one can decouple from the other, Internal Logistics plays a more 
significant role in controlling processes in order to route the hospital to a substantial 
improvement of the resources allocated. The review of business practices at 
healthcare centres aiming at improving the exploitation of these resources, increasing 
their effectiveness and efficiency, should allow better control of costs to assure the 
quality of the overall customer services (Massó, 2007). 
Internal Logistics 
Demand Management 
Operational Services 
External Logistics 
Auxiliary Services 
Figure 7: Basic activities taking place in a hospital (Chow and Heaver, 1994) 
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2.3. Flows in a hospital 
The mentioned above logistic activities involve the management and coordination of 
the different flows of the hospital: physical flows, flow of information and flow of 
money (Nsamzinshuti, Caroline and Ndiaye, 2014). 
As far as the physical flows is concerned, as Hassan (2006) described, there are 7 
different physical flows in the hospital: 
Flow in the hospital Service responsible for the flow 
Patients Care providing units 
Pharmaceutical flow: 
Drugs 
Sterile medical devices 
Bandages 
Pharmacy 
Hospitality flows: 
Laundry 
Catering 
Waste 
 
Economic service (administration) 
Kitchen (administration) 
Subcontractors (externalized) 
Table 1 Flows and the responsible service (Adapted from Hassan, 2006, p. 70) 
 
Not all of the mentioned flows are as important in terms of cost, quality and safety of 
the care provided. The principal flow of hospitals is the flow of patients, contrarily to 
other supply chain where goods are the principal flow. In the healthcare sector, 
without patients, there is no any other flow.  
 
The flow of information is indispensable to ensure a quality delivery of healthcare due 
to healthcare organizations provide valuable services that rely on large amounts of 
high quality information (Hughes, Cain and Haque, 2008). Aims at coordinating, 
synchronizing and monitoring all processes and physical flows that are carried out in a 
hospital, which are composed of multiple activities by different actors, on different 
locations, at different times. Therefore, information has to ensure the traceability of 
the activities and products. It is the result of a meaningful interpretation of data 
(Nsamzinshuti, Caroline and Ndiaye, 2014). 
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The flow of money in a hospital is determined based on the money that all activities 
taking place within the organization generate and their associated cost. The flow of 
funds of a Belgian hospital financing system is very complex. The 80% of funds come 
from a fixed prospective budget system based on so-called "justified activities" for 
services of accommodation, emergency services and nursing activities in day 
hospitalization, as well as a fee-for-service system to the service provider, which funds 
medical and medico-technical services and paramedical activities. The remaining part, 
is received from multiples and different sources. Payments are collected through direct 
payments of the patient, which afterwards are partly reimbursed to him by his sickness 
funds to the hospitals, or through the third-party system governed by direct payments 
of the sickness funds to the hospitals. (Gerkens and Merkur, 2010, pp. 102-103) 
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3. Pharmaceutical Supply Chain in Hospitals 
The aim of this section is to study and analyse the supply chain of pharmaceuticals in a 
hospital. To meet this objective, a review of existing methodologies for the inventory 
control and management regarding pharmaceutical products is provided. 
3.1. Introduction to Pharmaceutical Supply Chain in Hospitals 
In a healthcare logistics and supply chain, pharmaceuticals play a crucial role in the 
healthcare industry due to the importance of their availability at the right time, in the 
right place, in good conditions to the right customer. Their role is indispensable to 
deliver  healthcare  services  to  patients,  hospital’s  principal  objective. 
 
Important to take into account is that pharmaceuticals make up between 15-20% of 
the costs of a hospital due to the significant costs of the products and their storage 
and control requirements (Landry and Beaulieu, 2001). 
3.2. Pharmaceuticals Management in Hospitals 
In this section, a review of the management of pharmaceuticals throughout the 
hospital supply chain is given. To achieve this objective, it is conducted a study with 
regards the flow of pharmaceuticals within both, the healthcare sector and the main 
organization, as well as an overview of pharmaceuticals distribution methodologies. 
3.2.1.  Triggering pharmaceuticals supply chain 
Once a patient enters a hospital, a diagnosis according to patient's symptoms and the 
results of medical tests required by physicians is made and a treatment plan is 
prescribed. This is what triggers pharmaceuticals supply chain along the hospital. 
 
There are two ways of prescribing, by using traditional handwritten drug charts or 
electronic prescriptions (ePrescriptions). As has been mentioned in the first chapter, in 
this study it is assumed the use of ePrescriptions as part of EHR systems. 
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3.2.2. Physical Flow of Pharmaceuticals 
3.2.2.1. In the Healthcare Sector 
As Vila-Parrish and Ivy (2013) described, the conventional hospital inventory system is 
based in a multiple echelon (or physical location) supply chain. It takes into 
consideration both, the external and the internal supply chain.  
 
In a three-echelon supply chain, pharmaceuticals arrive to the hospital from vendors, 
manufacturers and distributors and are stored in the hospital storeroom: the central 
pharmacy. According to the orders, from there they are transferred to the different 
clinical departments of the hospital (such as emergency, intensive care, oncology, 
cardiology or coronary care, the catheterization laboratory or cath lab, and surgery), 
where pharmaceuticals are distributed to their satellite pharmacies located in the 
Patient Care Unit, so-called PCU (Landry and Beaulieu, 2013, p. 467). Then, 
pharmaceuticals can be administered to the corresponding patient. This supply chain is 
represented as follows: 
 
 
 
 
Figure 8 Three-echelon supply chain distribution (adapted form Rivard-Royer et al., 2002) 
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In some organizations it is also considered a stockless inventory system, distribution 
so-called two-echelon supply chain. In healthcare context, the term stockless inventory 
system implies that products are stocked at the distributor or manufacturer. In this 
case,   orders   are   placed   from   the   hospital’s   units   directly   to   these   upstream   supply  
chain partners. Therefore, this system bypasses the hospital level.  
 
 
Rivard-Royer et al. (2002) proposed a hybrid approach combining the conventional and 
the stockless inventory system (Vila-Parrish and Ivy, 2013, p. 453), which basically 
consisted on distributing case quantities, generally by distributors, in a two-echelon 
supply chain system, and bulk purchases in a three-echelon system.  
 
There have been several studies about these multiple echelon distribution system. 
Nicholson et al. (2004) and Zhu et al. (2005) compare both of them. The results 
suggested cost savings without sacrificing customer service for the two-echelon 
distribution network rather than the three-echelon methodology. However, a hospital 
cannot run only under two-echelon distribution system because most of the times 
patients cannot or are unwilling to wait for the order to be filled by outsourced 
suppliers (Woosley, 2009). 
Figure 3 Two-echelon supply chain distribution (adapted form Rivard-Royer, 2002)  
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3.2.2.2. Within the hospital 
After having a general overview of the healthcare sector supply chain, a flow diagram 
illustrating the flow of pharmaceuticals is presented. This is a diagram that comprises 
all basic elements of the system: suppliers, resources, inventories, physical flows and 
information flows (Lockamy and Mc Cromack, 2004). 
 
 
Actors involved  
Different actors with different goals perform the diverse activities involved in the flow 
of pharmaceuticals. They are described in the study carried out by Nsamzinshuti et al., 
as follows (Hassan, 2006; Di Martinelly et al., 2009; Baboli and Guinet, 2009; Vila-
Parrish et al., 2013): 
x External 
o Suppliers: Pharmaceuticals are requested by the Purchasing 
Department or Material Management Department of the hospital. They 
are supplied from distributors, manufacturers, wholesalers, vendors. 
Care providers Care Units 
Technical services 
Distribution and delivery 
Patient
s Administration 
Order 
Suppliers Manufacturers 
Wholesalers Hosp
ital rec
eption 
Pharmacy 
Raw materials 
Drugs 
Medical devices 
Bandages 
Production of drugs 
Return 
Prescription Information about situation 
Transport 
Return 
Stocks Flow of goods Flow of information 
 
Figure 9 Flow diagram pharmaceuticals (Adapted from Nsamzinshuti et al., 2014) 
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When it comes to sourcing there is a trend towards centralization of 
purchases across hospitals.  
o Transporters: Transfer of orders to the hospital. They have to assure 
their proper delivery. 
x Internal 
o Prescriber: Prescription of pharmaceuticals is done by physicians in the 
frame of the treatment they deliver to a patient. It is patient-specific, 
written and signed by the treating physician. For the choice of the 
pharmaceuticals, physicians have a formulary containing all products 
the pharmacy should always have in stock. The formulary is established 
in Medical Pharmaceutical Committees by agreement between 
physicians and the pharmacy. In these Committees, it is also decided 
upon the having in stock the branded product or its generic 
counterpart. Still, physicians have the possibility to order other products 
so they have freedom of prescription. (Agentschap Inspectie Welzijn, 
Volksgezondheid en Gezin, Afdeling Welzijn Gezondheid, 2009). 
o Pharmacists: They are obliged by law to validate prescriptions, which 
represent  the  beginning  of  pharmaceuticals’  flow.  Pharmacists  manage  
and monitor the pharmaceuticals flow so are responsible of ensuring 
the quality of this flow. This involves delivering the right drug, at the 
right moment (time), at the right place (patient), in the right quantity 
(dose) and for the right use (route) (Baboli and Guinet, 2009; Ebel et al., 
2012). Pharmacists are also in charge with assuring the right inventory 
levels. 
o Preparer: Deliveries are prepared based on prescriptions or inventory 
management. There are two kinds of preparations. At first, there are 
those whose preparation is made by the pharmacists, manufactured 
within the hospital pharmacy from raw materials. Apart from these, 
there are those that refer to the picking and packing of prescribed or 
stored pharmaceuticals that have to be routed to the units and patients. 
Pharmacists can perform this activity, although it is mostly carried out 
their assistants. 
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o Handlers: The person (a pharmacy assistant, a nurse or a logistics 
support)  transferring  the  prepared  orders  from  the  hospital’s  pharmacy  
to the ultimate point-of-use.  
o Administrator: The person who dispense and administer the 
pharmaceuticals to the appropriate patient or point of care. The nurses 
perform this activity, although occasionally could be the physician.  
o Patient: The person initiating the pharmaceutical flow when in need of 
pharmaceuticals to cure illness. At the same time, he also represents 
the latest step in the flow of pharmaceuticals, when their 
administration is received. 
A part of this pharmaceuticals flow is push; triggered by demand previsions, market 
planning and distribution approach. Demand provisions are mostly based on past 
consumption. Another part is pull, triggered by the real demand. 
In the following sections, it is provided a general overview regarding the supply chain 
of a hospital's pharmacy, the inventory management and the supply chain within the 
hospital (distribution system adopted) in terms of pharmaceuticals. 
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The described distribution systems include activities of pharmaceuticals distribution 
from hospital storeroom or suppliers to satellite pharmacies located at the PUCs. Then, 
from there, healthcare providers, usually nurses, administer the pharmaceuticals to 
the ultimate point-of-use with the help of trays.  
All of these inventory management methods are based on periodic reviews systems, 
either both, by using fixed-interval reordering process and/or order point logic. This 
means that with the help of different models of inventory control, it is possible to 
determine the different parameters (review period duration, maximum inventory 
level, order point, reordering quantities and safety stock) that may guarantee a right 
balance between ordering costs and inventory carrying costs. However, as has been 
seen, this is a complex task. To ensure proper operation of the supply chain, efforts 
have to be focused on several aspects such as the track of items through the supply 
chain as well as requests for orders whether replenishment is needed, the handling of 
products by clinical staff in order to reduce and eliminate human errors and 
communication between the different points-of-use where pharmaceuticals are 
required and the main responsible of inventory management and control.
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3.3. Inventory Control 
Some of the most prevalent and significant problems facing the healthcare supply 
chain involve the area of inventory control. It is a very complex task mainly due to the 
amount of products inventoried, which many are perishables, and the daily changing 
demand for pharmaceuticals. The availability of pharmaceuticals is a crucial factor in a 
hospital’s   ability   to  provide  effective,   timely   and   safe  patient  outcomes.   That   is  why  
researches and studies have been carried out in order to improve inventory efficiency 
(Smith, Nachtmann and Pohl, 2012; Vila-Parrish and Ivy, 2013, pp.447-449). 
 
After having seen the different distribution methods for pharmaceutical products, it is 
interesting to take into consideration the models that hospitals establish as inventory 
control strategies or techniques. That is, the criteria followed to replenish inventory 
from suppliers. Its analysis is under Materials Management Department (or Purchase 
Department, according the literature reviewed) responsibility. It implies selecting the 
right type of classification for materials and then applying appropriate techniques or 
models for inventory control. 
3.3.1. Classification systems for materials 
Classification systems have been developed and implemented in order to create a 
simple method for improving inventory costs and service levels. Hospitals often use 
ABC inventory classification strategy. The ABC analysis, also known as Selective 
Management   principle   or   Pareto’s   Law,   divides   an   inventory into three categories. 
Aims at providing a mechanism for identifying the impact of the different items on the 
overall inventory cost. It gives a measure of inventory importance to each item. Thus, 
it helps to determine adequate management and controls per each established 
category (Reddy, 2008). Hereunder are proposed selective controls procedures to be 
adopted for ABC classified items.  
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Control procedure 
A 
High Consumption 
Value 
B 
Moderate 
Consumption value 
C 
Low Consumption 
Value 
Type of control and 
authority 
Very strict control. The 
controller should have 
great authority. 
Moderate control. 
Controller may be 
from the middle 
management. 
Low control. Powers 
can be delegated to 
the user departments 
to determine stock 
level. 
Quantity of safety 
stock 
Very low or practically 
nil, combined with 
frequent ordering 
and/or staggered 
supplies. Possibility of 
stockless strategy. 
Low. Ordering can be 
done monthly or 
quarterly 
High. Bulk ordering. 
Half yearly or annual 
orders to take 
advantage of bulk 
discounts. 
Consumption 
control 
Should be done 
regularly: weekly or 
daily. 
This period can be 
extended to a 
fortnight or a month. 
This period can be 
extended to a 
quarter. 
Material planning 
Should be accurate. 
Database should be up-
to-date. 
Can rely on historical 
data, past 
consumptions.  
Estimates are 
sufficient.  
Application of value 
A concerted attempt 
should be made at 
value analysis, waste 
reduction, obsolete and 
surplus reduction. 
Moderate attempts 
are sufficient. 
Annual reviews are 
sufficient. 
Number of suppliers 
High. Centralise control. 
Require short lead 
times. 
2-4 sources. Shorter 
lead-time is 
preferred. 
1-2 sources. Annual 
or half-yearly 
purchase. 
Decentralised 
control. 
Table 3Levels of hospital supply inventory management control in an ABC classification category 
(Adapted from Reddy, 2008) 
Therefore, the ABC analysis helps to rationalise the number of orders by establishing 
priorities and reduce the average inventory during a specific period, which has an 
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impact on cost reduction. However, ABC analysis has a significant limitation: it 
indicates nothing regarding profitability or criticality of the items, so importance is 
given to an item on the basis of its consumption value. As a consequence, in order to 
accurately classify materials, other analyses have emerged that can add significant 
value to inventory management. One of the most common is the one proposed by 
Gupta et al. (2007), which focuses on the coupling of ABC and VED method. VED 
analysis is based   on   the   criticality   of   an   item.   “V”   is   for   vital   items  without  which   a  
hospital   cannot   function,   “E”   is   for   essential   items  without  which   an   institution   can  
function  but  may  affect  the  quality  of  the  services  and  “D”  stands  for  desirable  items  
that do not hinder hospital functionality (Vila-Parrish and Ivy, 2013). 
Information about other types of Selective Controls can be found in the ANNEX VI. 
3.3.2. Techniques for Inventory Control 
In line with these analyses, hospitals set inventory control strategies or models in 
order to define some criteria to replenish inventory. This can be a complex task. The 
major problem is the uncertainty of demand. Demand for pharmaceuticals is based on 
the patient population in the hospital, which is uncertain and varies through time due 
to season factors (e.g., flu season) (Vila-Parrish and Ivy, 2013, p. 451). 
 
According to the interview with Mr Bruno, Warehouse Manager at Hospital Logistics, 
the main supply chain strategy used for replenishment of pharmaceuticals in hospitals 
is a Min-Max strategy (periodic replenishment model). This strategy allows placing 
orders to suppliers in variable quantities and variable periods based on historical data. 
It is used for the whole range of products' references that can be found in the central 
pharmacy. Its main advantage for the case of study is that it also allows inventory 
control despite the uncertain demand. Rather, it takes into account possible 
unforeseen spikes in demand by carrying safety stocks. Mr Bruno pointed out the 
importance and necessity to keep pharmaceuticals as safety stocks in order to meet 
the uncertain demand. Their stored quantity may vary frequently (e.g. whether 
supplier is not reliable, or due to his geographical location, changes on products, peaks 
in demand, etc.). The main constraint of the strategy is the associated holding costs 
involved.  
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Hospitals are currently working on improving and optimising this strategy in terms of 
effort, stock stored and associated costs. Thus, hospitals are starting to use strategies 
or models of purchasing that may vary from one product to another. That is mainly 
due to the broad variety of products (drugs, medical devices and materials) and their 
classification and criticality in the supply chain and service given by healthcare 
professionals. 
 
So far, as Mr Bruno has explained, the common one aims at classifying 
pharmaceuticals  into  “fast  movers”,  “middle  movers”  and  “slow  movers”  and  then  set  
an inventory pattern for one of each them: - Fast movers: Min-Max strategy. Inventory ordered in variable quantities and 
variable periods. - Middle movers: Fixed-Time Period Model strategy. Inventory ordered in 
variable quantities in fixed periods. - Slow movers: Inventory ordered in bulk or big orders in one time. 
Depending upon usage or demand from the different points-of-use of the products 
required, the orders follow a two-echelon or three-echelon distribution, as an hybrid 
approach distribution.  
During the interview, Mr Bruno emphasized the significance of this classification, 
which takes into account not only the value of inventory seen as days of stock and 
volume, but also their economic value, as a combination of both aspects.  
3.3.3. Production of pharmaceuticals 
Not all pharmaceuticals purchased are directly administered to patients or sent to a 
point-of-use. Some pharmaceuticals are produced on site from raw materials. The 
consideration of their production strategy, make-to-order (MTO) or make-to-stock 
(MTS), is complimentary to the classification and prioritization of pharmaceutical 
supplies as well as any inventory management strategy (Vila-Parrish and Ivy, 2013, 
p.450). 
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4. Value chain analysis 
The value chain analysis is applied to identify both, the core activities that take place in 
an institution as its add value. In this section, firstly it is provided the value chain 
analysis for the hospital institution. It is given the description of the principal activities 
that create value for the main hospital activity, the delivery of care. Secondly, the 
same framework is used to analyse one of the hospital support activities, the 
pharmaceutical supply chain. 
 
This way, the study provides an overview of the activities that add value to the 
pharmaceutical supply chain and their link or impact on the delivery of the main 
hospital  service,  patient’s  care.  This  will  allow  us  to  analyse  the  added  value  that  may  
create the usage of EHR and ePrescriptions to the pharmaceutical supply chain as well 
as the main institution. 
4.1. Concept  of  “value”  adapted to the hospital 
In   the   healthcare   context,   the   notion   of   “value”   under   hospital’s   perspective   is  
composed of two elements: the quality of care delivered to patients and the 
productivity and competitiveness of the production system of care of the hospital. The 
performance of the system is measured by efficiency and effectiveness of activities 
that use technical, human and financial resources to produce care of quality for the 
patient (Di Martinelly, Riane, and Guinet, 2009). 
 
The primary activities of the value chain are devoted to care patients. As the model 
introduced by Michael Porter in 1985, they are divided into 5 sub-categories: 
x Admission Logistics (Inbound Logistics):   processes   associated   with   patient’s  
admission and management of their documents and information. 
x Care (Operations): processes associated with the management of healthcare 
delivery (diagnose and treat of the patient). 
x Discharge Logistics (Outbound Logistics):   processes   associated   with   patient’s  
discharge.  
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x Marketing and sales: processes associated with the financial return of care. 
That is, invoicing to patient and third party payers, information exchange with 
state-controlled organizations and price setting activities. 
x Service: processes associated with care activities that can add value to them. 
The primary activities are supported by the support activities, which provide human, 
technical and material resources. 
 
4.2. Adapted to pharmaceutical supply chain 
The main objective of pharmaceutical supply chain is to make pharmaceuticals 
available to the patients or points-of-use. Thus, value is based on the ability to 
coordinate the activities from the pharmaceuticals and their supply chain. 
 
According to Pitta and Laric (2004), which provide a model of the healthcare value 
chain, it is provided a description of the value chain for pharmaceutical supplies. That 
is, who and how creates value for the pharmaceutical supply chain.  
 
 
Figure 5 Value chain adapted to hospital (adapted from Di Martinelly, Riane and Guinet, 2009) 
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The first two participants comprising the value chain are the patient and their 
exchange with the health care provider or physician. Although patients are not part of 
the pharmaceutical supply chain, as they are its main cause and beneficiary, they can 
add value to the chain. Patients are the initiators of the information flow as they are 
the first givers of information. In the medical consultation, patients provide value 
information regarding the matter/s or issue/s that brought them to the hospital, which 
is necessary to adequately address whatever needs they might have. The research of 
Pitta and Laric (2004) showed that patients are more willing to share important, if 
private, information with their healthcare providers when they believe this 
information is needed for medical purposes and when they trust the confidential 
nature of the patient-doctor   relationship.   According   to   patient’s   symptoms   and  
information provided, the health care provider or physician must contribute to the 
value chain by first properly diagnosing and then prescribing a treatment plan. To 
better perform these tasks, physicians need to build confidence with patients in the 
medical consultation in order to receive all possible information. The more information 
given, the more valuable information can be extracted, so the more accurate diagnosis 
can be made. In the majority of treatment plans, there are involved prescriptions. 
Their prescribed pharmaceuticals trigger pharmaceuticals supply chain. Then, another 
group enters the value chain, pharmacists, which dispense pharmaceuticals, and other 
providers of medical equipment and services - this last group is not part of the 
Figure 6 Participants and relationships in the healthcare value chain (Pitta and Laric, 2004) 
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pharmaceutical supply chain but has a crucial role. They provide additional data 
(battery  of  diagnostic  tests…)  required by physicians, which is the basis of the diagnosis 
and  treatment  plan  prescribed  as  well  as   information  given  by  patients.  Pharmacists’  
main added value relies on further investigating the medical history, specifically as it 
relates to medications, of patients in order to determine any potential risks or 
interactions that may result from the addition of a new prescribed drug. The next 
addition to the value chain is the hospital and the related services and procedures that 
may be included in the entire treatment of a patient. Hospitals add value by facilitating 
the storage and flow of information through the different activities that shape the 
supply chain of pharmaceuticals. The next member of the healthcare value chain is 
health insurers, which includes both public and private entities responsible for 
providing financial support to those receiving care. Insurers may request for patients 
information regarding their diagnosis and treatment plan. May have an effect on them 
whether certain procedures are not approved because of its high cost. Employers are 
the next participant group. Value is obtained by negotiating better benefits for groups 
of people as opposed to those offered to individuals. The next addition is government 
as influential party on the system. Finally, Pharmaceutical manufacturers are the last 
participants. Their added value is based on designing, producing and bringing 
pharmaceuticals to market. To do so, they need information from providers and 
patients so as to know what the future needs of patients are. That knowledge 
improves the performance of the value chain. 
 
According to the explanation above, the value chain adapted to pharmaceuticals 
supply can be summarised as follows: 
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Figure 7 Value chain adapted to pharmaceutical supply chain (adapted from Di Martinelly, Riane and 
Guinet, 2009) 
 
As for pharmaceutical supply chain support processes is concerned, they are mainly 
the same as those of the hospital, but less specific. 
 
To conclude this section, it is important to mention that among all the participants and 
activities that take place in the value chain of pharmaceuticals supply, the information 
system plays an important role. There is a necessity to process, transfer and convey 
amounts of quality information across the different members of the chain. A quality 
flow of information has to be guaranteed. Moreover, the information system has to 
support a perfect coordination between the patient flow and the pharmaceuticals flow 
to allow an optimal management. 
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5. Opportunities to increase value with EHRs and ePrescriptions 
 
With the implementation of Electronic Health Records (EHR) in a hospital, what means 
the adoption of Electronic Medical Records (EMR) and Electronic Patient Records 
(EPR), including Electronic Prescribing (ePrecription) for the case of study, there is an 
opportunity to increase value to the processes and activities that take place along the 
pharmaceutical supply chain of a hospital. They are presented below. 
5.1. In the Pharmaceuticals Management  
Improvement or added value to the trigger point of pharmaceuticals: The prescription 
of  a  patient’s  treatment  plan 
In a hospital, EHRs and ePrescriptions facilitate tools for decision support in  patient’s  
diagnosis and prescription of a treatment plan, as: 
x Can help the physician by generating reminders and alerts (e.g. to detect drug 
adverse effects) or by suggesting, from the patient data, diagnosis or 
therapeutic strategy 
x During medical consultations, physicians can electronically and remotely 
consult   the   patients’   medical   history   (EHR), which are virtually stored and 
available in the database anytime. This valuable information, along with a 
rigorous analysis of the information provided by patients, their presented 
symptoms and the results of analyses required by physicians (if needed), as 
well as the possibly added decision support tools (which can help the physician 
by generating reminders and alerts (e.g. to detect drug adverse effects or by 
suggesting   diagnosis   or   therapeutic   strategy   from   the   patient’s   data),   may  
contribute the development of an accurate treatment plan for patients.  
x EPrescriptions open up the potential to capture the prescribed treatment plan 
electronically in a transferable manner to and from other systems and add 
decision support tools. Then, specifying, its main added value is in: 
o Enabling test orders to be triggered from within the system, and for 
these test results to be posted to the system. 
o Having the ability to add decision support tools to assist the prescriber 
in pharmaceutical selection (such decision support tool may be 
classified into active decision support or passive decision support. Active 
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decision support functions provide clinical alerts to the user 
automatically as part of the workflow of the system, without the user 
having to actively seek the clinical information. This mechanism is built 
into the ePrescription system software. On the other hand, passive 
decision support functions are pharmaceutical information reference 
sources mounted on Internet, an intranet or a local server. This clinical 
decision support warnings and information may include some or all of 
the following: sensitive checking, drug interactions, duplicate 
therapy/drug doubling, precautions/contraindications, dose checking, 
formulary status and monitoring warnings (Goundrey-Smith, 2013)). 
 
Improvement or added value to the Pharmaceutical Supply Chain 
Many of the inefficiencies of existing processes in pharmaceutical supply chain in 
hospitals surround the way in which prescriptions of the medical consultations (or 
wards) are filled with pharmaceuticals from the Materials Management Department. 
 
The networked ePrescription system offers a seamless transmission of prescriptions 
between the different workstations of the supply chain (medical consultation - 
satellite pharmacies - Material Management Department - pharmaceutical 
administration or point-of-use) for placing orders that need to be administered to 
patients. Instead of being the clinical staff that is in charge of transcribing and moving 
handwritten prescriptions in drug charts, the ePrescription system creates an 
electronic link between the workstations. As a consequence, this flow of information is 
improved and adds value to the chain as follows: 
x Information is transmitted in a more transferable manner that is more fast, 
structured and secure than paper-based documents. 
In a study in Scotland, Fowlie et al. (2000) noted a significant reduction in 
inpatient prescribing errors after the implementation of ePrescriptions. The 
prescription error rate fell from 7.4%, to 7% one month after implementation 
and then to 4.7% twelve months after implementation (p<0.001). 
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x Providing real-time display of prescribing information along the network, what 
has an impact on the chain based on: 
o The impossibility to lose information along the chain. That is, 
prescriptions cannot get lost (or part thereof), in comparison with 
paper-based drug charts.  
 
 
 
o A reduction in pharmaceutical ordering turn-around times. 
 
 
 
 
x Transcription process, legibility and completeness of prescriptions are 
improved. As physicians often do prescriptions in a hurry, handwritten 
prescriptions may be illegible or incomplete. Consequently, nursing or clinical 
staff may have doubts about what is written down on drug charts, so that they 
may have to query prescriptions before they administer any pharmaceutical or 
place orders to the Material Management Department. With ePrescribing: 
o  Legibility is improved since physicians prescribe pharmaceuticals in a 
computerized manner.  
 
 
 
 
 
 
 
 
 
 
In a study of 317 general practitioners in Yorkeshire, 17% said that the 
loss of chart drugs had led to wrong drugs being given (Smith, 2004). 
One US study has identified a 64% average reduction in medication 
ordering turn-around time following implementation of an ePrescription 
system (Koppel et al., 2005). 
A study assessing the quality of written inpatient prescriptions found 
that of 4.536 prescriptions 4 to 10 percent were illegible or ambiguous 
(Jenkins, Cairns and barber, 1993). 
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o Completeness is also improved since the ePrescription system cannot 
consider that a prescription is finished whether specific fields are not 
filled out. 
 
 
 
 
 
 
 
 
 
 
 
 
o Transcription errors, which are commonly found when orders need to be 
triggered   by   clinical   staff   transcribing   information   from   physician’s  
prescription, are avoidable since, as said, physicians prescribe 
pharmaceuticals in a computerized manner.  
 
 
 
The use of ePrescriptions at the Wirral Hospitals had increased the 
number of complete and correct doses on medication charts from 17.7% 
to approaching 100% (Farrar, 1999).  
The effect on legibility and completeness of prescriptions was compared 
with handwritten prescriptions. A total of 2.180 prescriptions for 267 
patients on 5 wards (1.217 before and 963 after computerisation) were 
assessed against the hospital standard for prescription writing as 
specified in the British National Formulary. Computerised prescribing 
significantly (p<0.0001) improved the legibility and completeness of 
prescriptions compared with hand-written instructions (Smith, 2004).  
Figure 10 Example of illegibility in handwritten prescriptions 
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Several studies have analysed the effect of implementing ePrescribing systems 
assessing the quality of services delivered in medical practices, the main objective of a 
hospital. There are outlined a couple of examples hereunder: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The networked EHR system offers a seamless storage and transmission of patient 
information and medical practices (EMR and EPR) between the different 
workstations of the supply chain that can make use of this information (medical 
consultation – central pharmacy – pharmaceutical administration or point-of-use) for 
consulting, modifying or introducing information   regarding   patient’s   treatment   plan  
Some 11% of errors are as a result of the transcription process. Bates et 
al. indicated that the rate of non-intercepted errors arising from the 
transcription process was reduced considerably by 84%, from 
1,3events/1000 patient days to 0,2 events/1000 patient days (Bates et 
al., 1998). 
Shulman et al. (2005) compared the use of handwritten prescriptions 
with electronic prescribing (without decision support functions) on an 
intensive care unit at University College Hospital, London. The study 
found a moderate reduction of medication errors with the ePrescribing 
system. The medication error rate fall from 6.7% (69 errors on 1.036 
prescriptions) for handwritten prescriptions to 4.8% (117 errors on 2.429 
prescriptions) for electronic prescribing (p<0.04).  
The medication administration error, from 9% prior to implementation, 
fall to 6% after one month and then to 5.4% twelve months after the 
implementation (p<0.001). It is interesting to note that medication 
administration errors involving intravenous drugs and controlled drugs 
were omitted from these figures due to the complexity of scenarios, 
which could affect the overall medication administration error rate 
(Fowlie et al., 2000). 
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prescribed (the function that is carried out depends on the clinical staff that performs 
them). This opportunity to access to all this information remotely can add value to: 
x Enable record security (EHRs are likely to be more secure than paper records, 
although it depends on the design of the system). 
x Medical practices since patient’s   valuable   information   can   be   provided   to  
authorized healthcare professionals in front of any unforeseen circumstance, 
at any time, with more structured, legible and complete record contents. 
x Pharmacists’  activities, which can have more working time available to devote 
to near-patient clinical activities. That is, monitoring new treatments, 
assessing side effects and providing advice to other healthcare professionals. 
The use of EHRs also facilitates communication and transmission of information 
between the hospital and health insurers when they may demand patient's medical 
information before covering tests or treatment plans ordered by healthcare providers. 
5.2. In Inventory Control Strategies 
EHRs   in   a   hospital   capture   patient’s   medical   history,   what   also   can   bee   seen   as   a  
capture of medical practices. EPrescribing captures medical prescriptions according to 
treatment plans prescribed to patients. All this data can be exported and be collected 
and serve of great use to the Materials Management Department of the hospital to 
improve and optimize Inventory Control established policies. 
 
Therefore, these records provide valuable information regarding the demand and use 
of pharmaceutical products in a hospital. This allows gathering information for an 
accurate study of classification of pharmaceuticals and analysis of their demand, 
which, as said, is the major problem in determining inventory control strategies or 
models as it is uncertain, stochastic. As information is collected compactly, new or 
more accurate statistical models describing demand can be found, as well as Markov 
chains that can take place. 
5.3. In the organization 
Both the use of EHR and ePrescription systems as their impact on the pharmaceutical 
supply chain efficiency brings some benefits to the organization, as they are described 
below.   
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Clinical system intraoperability 
EHRs and ePrescriptions allow a better operability between the different departments 
and stakeholders of a hospital. These applications open up the potential to be 
interacted or interfaced with other IT systems of a hospital in an integrated manner, 
what can benefit medical practices and streamline business processes of a hospital. 
This is also a key driver for regional, national and even international healthcare IT 
programs, where information may be transferred to a central spine from which other 
healthcare providers may retrieve it as the need arises. 
 
Streamlined workflow for healthcare providers, users of the systems 
Healthcare professionals of all disciplines have a duty of care towards their patients, 
which entails an obligation to ensure that patients are treated in a way that fulfils legal 
and ethical requirements. However, to do so, healthcare professionals may work under 
operational pressures from the healthcare organization to treat patients as quickly and 
efficiently as possible and to achieve statistical benchmarks and service level targets 
(Goundrey-Smith, 2012). Sometimes, these objectives cannot seem to go together. 
However, there is an opportunity to achieve both objectives whether workflow of the 
healthcare professionals is streamlined by the appropriate and accurate use of EHRs 
and ePrescriptions. Nevertheless, it is important to take into account that this may 
imply less time spent on administrative staff by nurses, while physicians may have to 
spend more time on the computer. 
 
Security  and  confidentiality  of  patient’s  information 
Traditional paper-based drug charts are liable to being lost or viewed by unauthorized 
users. Contrarily, EHRs and ePresciptions are a networked closed system whose 
information access is only permitted to authorised users and only in order to perform 
functions that are appropriate to their role. 
 
Cost reduction 
In comparison to traditional paper-based health records, the introduction of EHR and 
ePrescription systems will lead to savings by reducing the amount of paper and 
consumables used (in terms of charts, paper, pens, etc), the wasted staff time due to 
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inefficient paper-based systems and processes and possible litigation costs when 
errors are made.   
 
Improvement of the quality of care delivered  
As these systems improve the efficiency of both the prescription process as the 
pharmaceutical supply by automating processes, healthcare professionals have the 
opportunity to release time and engage in more patient-centered activities, which 
require intuitive input that only human beings can provide. These tasks may include 
detailed history taking, medicines review, health education, clinical research, 
evaluation of resources and technology that could be used to facilitate further service 
developments, etc. That is, there is a tendency of healthcare providers to move away 
from product and process-centered work towards patient-centered work. As a result, 
as has been seen, there is a reduction of pharmaceutical administration error to 
patients, leading to a better quality of health care delivery.  
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6. Possible causes of inefficiencies with EHR and ePrescription systems 
As has been seen, EHR and ePrescription systems can improve both the supply chain 
and the hospital efficiency. However, there are some points that may cause 
inefficiencies to the chain that are important to take into account. 
 
First of all, the way on which these systems are designed plays an important role in 
their implementation and proper functioning in a hospital, specifically for applications 
such as EHRs and ePrescriptions where there is a need to present complex information 
in a way that enables appropriate professional decision-making. For this reason, the 
easier and usable they are for users to operate, the less dysfunctions and inefficiencies 
may be caused. In order to gain maximum benefits form these systems, it is essential 
that system designers take into account the comments, views and aspirations of 
clinical users. 
 
Secondly, possible resistance to change by healthcare providers may appear in front of 
the introduction of new technologies to support medical practices. That is why training 
and showing the functionalities, advantages and added values of these systems to 
healthcare providers are crucial to improve their point of views regarding the 
dissemination of new technologies. 
 
Furthermore, initiatives in case of failure or breakdown of the electrical system of the 
hospital, as well as damage or loss caused by possible virus, have to be taken into 
consideration also for these systems. Otherwise, there is no possibility to access to any 
information. 
 
Important to take into consideration is that there is a necessity to ensure a proper 
sharing   of   patient’s   data in line with appropriate legal requirements, information 
If they are not easy to operate, errors may occur. Prescribing errors mainly caused 
by omission of drugs (31%), incorrect selection of drugs (29,4%) and dose regimen 
errors (18,1%). The prescribing errors were found in 664 medication orders, out of 
7.920 orders for 1.038 patients (Abdel-Qader et al., 2010). 
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governance arrangements and professional standards. Appropriate confidentiality and 
data security measures have to take place. It is important to take into account that 
EHR systems must not be used inappropriately or in an unprofessional manner. 
Furthermore, EHR data should not be used for research purposes without the 
appropriate patient consent and ethics approvals being secured from the appropriate 
authority. In any other case, these systems might cause harm to the patient and, as a 
consequence,   to   the   hospital   and   the   systems’   provider   as   well.   For   this   reason,  
confidentiality and data security measures should cover, at least, an appropriate use of 
password or smart card technology for log in the EHR systems, data transfer and 
encryption, security of hardware devices and premises where equipment is used and 
training on confidentiality incidents. 
 
It is interesting to take into consideration that the drawbacks or disadvantages these 
systems may present can be alleviated or eradicated considering the proposed 
measures. 
 
At last but not least, before closing this section it is important to mention that the cost 
of acquisition and implementation of these systems in a hospital may be high. The 
main system and induced costs are related to costs of software and hardware, training, 
implementation, on-going maintenance and support. The dimension of this investment 
is variable, so it depends on the size of the hospital, the implementation cycle, the 
legacy systems involved and whether these systems can be integrated with the new 
software or not. However, various experts have commented on the costs of EHR 
implementation. For example, it has been estimated a total cost of $19 million, 
approximately, for a 7-year long EHR installation in a 280-bed acute care hospital with 
16 satellite clinics, a research institute, and a network of about 400 employed 
physicians (Menachemi and Brooks, 2006). 
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7. Conclusion 
After the analyse, it is an undeniable fact that Electronic Health Records (EHRs) and 
Electronic Prescriptions (ePrescriptions) systems can lead to increase efficiency in the 
pharmaceutical supply chain of a hospital.  
First of all, digitalization of information has a fundamental role. In comparison with 
handwritten prescription and paper-based drug charts, the computerization of 
information leads to a better durability, legibility, completeness and standardization of 
the records. As well, it is facilitated an accurate recording, display, transmission and 
exchange of information, what improves communication of electronic information 
between different stakeholders of the supply chain according to the IT system.  
On the one hand, the ePrescription system offers to a hospital the possibility to 
electronically   capture   patient’s   prescription   treatment   plan   according   to   patient’s  
symptoms, medical tests analysis and decision pharmaceutical support tools and opens 
up the potential to exchange these prescriptions between the different workstations 
and stakeholders of the networked system within the supply chain (medical 
consultation – satellite pharmacies – Materials Management Department – 
pharmaceutical points-of-use). On the other hand, the EHR system offers to a hospital 
the possibility to electronically store all patient information and medical practices, 
with the opportunity to add support tools, and exchange this valuable information 
between the different workstations and stakeholders of the networked system within 
the supply chain (medical consultation – central pharmacy – pharmaceutical points-of-
use and Hospital – Health insurers). 
As a result, it is not just the flow of information that is improved, but also the quality of 
information that is stored and transmitted, which consequently may improve the 
traceability and efficiency of the hospital's physical flow. 
The benefits these IT applications can have on the pharmaceutical supply chain can be 
manifold: from improving pharmaceutical prescribing and dispensing workflow to 
supporting new ways of working and pharmaceutical management and inventory 
control in hospitals. This way, EHRs and ePrescriptions have a beneficial impact on the 
primary activities of the value chain of the pharmaceutical supply chain. They improve 
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Inbound Logistics activities by facilitating the capture of valuable data, which can serve 
as   a   source   of   patient’s   data   and   lead   to   data   extraction   and   statistical   analysis   to  
provide information to develop and/or optimize inventory control strategies and 
models; Operations and Outbound Logistics activities as they open up the potential to 
support new ways of working in inventory management and distribution (e.g., unlock 
the potential to interface these systems with other IT applications such as RFID or 
barcode scanning for a better traceability of pharmaceuticals); Marketing & Sales 
activities by improving the flow of information; and Service activities since pharmacists 
can have more working time available to devote to near-patient clinical activities (for 
example, in monitoring new treatments, assessing side effects and providing advice to 
other healthcare professionals). 
EHR and ePrescription systems not only have a beneficial impact on the 
pharmaceutical supply chain, but also on the hospital enterprise. As seen, they allow 
improving the clinical system intraoperability and the security and confidentiality of 
patient’s   information,   streamlining   workflow   for   healthcare   providers   and   having   a  
cost reduction. These benefits improve the primary activities of the value chain of a 
hospital since Admission Logistics; Discharge Logistics and Marketing & Sales activities 
are mainly streamlined by improving the flow and quality of information and Care 
activities are improved thanks to streamlining workflow for healthcare providers and 
hospital’s  pharmacists. 
All these advantages obtained by improving the efficiency of activities within the 
supply chain and the hospital enterprise can be grouped into one: improvement of the 
quality of care delivered to patients, which is the main goal of any hospital. By moving 
away from product and process-centered work towards patient-centered work, as has 
been seen, there is a reduction of the risk of pharmaceutical administration errors to 
patients. There is also opened up a possibility for the patient to get more and better 
involved in its own care. 
At a regional, national and international level, the major objective of establishing 
homologated and standardized EHRs at the different healthcare facilities of the region 
is to set up a virtual portal for the storage of medical data and information, 
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electronically and easily accessible, in order to promote their interoperability, usability 
and health coordination. This way, it is allowed the free movement of patients, 
healthcare professionals and services across both Belgium, according to the Reference 
Directory service offered by the 2008 eHealth-Platform, and the Member States of the 
European Union, according to the Europe 2020 initiative in the healthcare sector.  
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Chapter 3: Roadmap for implementing EHRs in a hospital 
1. Introduction 
As has been seen in the first chapter, Huvenne (2012) analysed the current state of e-
health and EHRs technologies in Belgium and proposed a model for a nation-wide 
working implementation for both fields, based on a compilation of information from 
various authors, organizations and interviewees. As a reminder, the model consists of 
the following five phases:  
1. Preparation and promotion: Relates to the need to prepare the sector for the 
adoption of EHRs and its related aspects, which will lead to its implementation. 
Moreover, it also relates to the promotion of the changes that will need to take 
place within the different levels of the health sector. 
2. Selection: Relates to both the selection and integration of existing systems that 
will answer to the needs of the sector. 
3. Adoption: Refers to the moment when healthcare organizations start putting in 
place the efforts necessary so as to use EHRs to support their healthcare 
related activities. 
4. Exploitation: Refers to the moment from which the consecutive various aspects 
of EHRs (preparation level and environment and system development) have 
been accepted as the required answers by users and that their usage is 
propagated to the predefined user groups. 
5. Renewal/Reinvention: Aims at enabling implementation of EHRs to become 
dynamic. 
According to the study, at a national level Belgium can be seen as soon leaving the 
preparation and promotion phase to enter the selection one, although at a regional 
level, the Réseau de Santé Wallon (RSW) hub can be said to have already reached the 
selection phase and entered the adoption one. As was seen before, the reason why 
the process of implementing and adopting EHRs at a national level, hand in hand with 
ePrescriptions, has developing slowly is mainly related to two factors. In the first place, 
because of the aspects related to security, privacy and confidentiality to both patients 
and medical practices and professionals around these systems, which are not in 
agreement by the different stakeholders of the sector. Moreover, political tensions 
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seem to exist between the Regional level hubs and the Federal eHealth-platform on 
the way to integrate regional and Federal initiatives. In the second place, the slow 
development of the project is due to the role and the methods used by the 2008 
eHealth-platform are highly debated among institutions and medical professionals 
because of a lack of comprehension of the advantages linked to this service. In the 
second place, the slow development of the project is due to the role and the methods 
used by the 2008 eHealth-platform are highly debated among institutions and medical 
professionals because of a lack of comprehension of the advantages linked to this 
service. There is a low involvement of stakeholders in the processes, in particular 
medical professionals that are key users of these systems and who resist to change 
their ways of working due to a lack of knowledge regarding the impact that these 
technologies may have to their daily work and the healthcare sector, either at a 
regional, national or even international level. 
 
Therefore, after having seen in the last chapter the positive impact that EHRs and 
ePrescriptions may have not only on the pharmaceutical supply chain of a hospital, but 
also to the healthcare facility contributing to a better treat and care of patients, and in 
order to streamline the process of implementing and adopting these systems in 
hospitals, in this third and last chapter we make two proposals. In the first place, we 
propose to present the study of the impact of EHRs and ePrescriptions to the 
stakeholders that will be linked, in one way or another, to the process of 
implementation. This way, all of them will be informed and aware of the main reasons 
why this action needs to be taken and the advantages that may be obtained. In the 
particular case of Belgium this step is very important whether we want to get medical 
professionals more involved in the process and encourage them to give it a proper 
shoot. After that, we propose a roadmap for implementing EHRs, hand in hand with 
ePrescriptions, in a hospital. It aims at setting steps or procedure to implement these 
systems in the healthcare facility coping with the barriers of implementation reviewed 
in order to make the process productive. This would path the way to move away from 
the selection phase to the following stages and symbolize the first step to shape 
hospital’s   EHR   system,   which   then   will   allow   the   organization   to   join   the   regional,  
national and/or international EHRs network. 
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2. The implementation process of EHR and ePrescription systems 
2.1. Preliminary definition 
2.1.1. Definition of the objectives 
The first step towards the development of any project is the setting of goals and 
targets. In this case, this involves a thorough analysis of all processes and activities that 
are currently taking place in a hospital and the needs of the stakeholders users of the 
IT applications. Then, issues, inefficiencies and dysfunctions as well as opportunities 
for improvement have to be identified.  
 
Finally, the aim, the purpose and the scope of implementing EHR and ePrescription 
systems have to be clearly defined. 
2.1.2. Study of the economical and financial feasibility 
Before starting with the implementation of EHRs and ePrescriptions in the healthcare 
facility, it is necessary to evaluate whether the implementation of these systems is 
feasible or not.  
 
At first, to conduct a feasibility study, it is required an analysis of the current technical 
and operational resources and the ones required by the project (tools, knowledge, 
skills, experience, etc.). In the second place, it refers to the economic and financial 
resources that are needed to develop the activities or processes and/or to obtain the 
basic resources that should be considered (cost of time, cost of acquiring new 
resources and cost of implementation) in a EHRs implementation process. 
 
This analysis aims at estimating the costs that are involved from the acquisition and 
development up to the implementation of EHR and ePrescription systems which, 
according to the estimated benefits that will be obtained, makes it possible to 
estimate the return of investment (ROI) in order to justify the investment. 
2.1.3. Selection of the software provider 
In the case the project is feasible, it is possible to proceed with the selection of the 
provider of the EHR (EMR and EPR) and ePrescription systems. 
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The first step is to study the different options of providers available on the market (for 
instance, it would be interesting to take into consideration their previous experience in 
similar organization and support human and financial resources). Subsequently, 
technical and economic proposals for the specific needs of the institution should be 
requested to the providers that may present homologated systems (such as Mediwin, 
EMR for physicians, OmniPro or the one offered by Cegeka Healthcare) that comply 
with the law. Once the preliminary solutions have been presented, it is important to 
involve in decision-making the representative medical, operational and administrative 
staff from areas of the hospital that will be affected by the implementation of the 
systems. Their agreement and approval will enrich the solution and decrease possible 
resistance to change. 
 
One of the important points that should be taken into consideration when choosing 
the provider of the software is the additional service that offers. At least, some 
recommended services are:  
- License of the software solution and additional components required. 
- Due to the amount of software that are usually operating in a hospital for 
different processes, it is interesting to assess the feasibility of integration of 
these existing software to the new one. This way, user does not have to use 
multiple software at once. 
- Complementary technological infrastructure. 
- Training program for the personnel users and administrators of the system. 
- Consultancy and monitoring during the implementation process.  
- Maintenance and technical support to the systems and the technological 
infrastructure involved. 
2.1.4. Project planning 
Project planning relates to the use of schedules such as Gantt charts to plan and 
subsequently report progress within the project environment. 
 
After the project scope has been defined, all activities needed to carry out EHRs and 
ePrescriptions implementation should be listed and grouped into a work breakdown 
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structure. For an accurate planning, necessary resources and costs for each activity 
and the organization of the different areas of the project (project plans; workloads and 
management of teams and individuals) should be included. 
 
Once established and accepted, the plan should become the baseline of the project. 
The progress of the project should be measured on this alignment throughout its life. 
2.2. The process of implementing EMRs and EPRs 
2.2.1. Technology infrastructure 
The first step to proceed with the implementation of EHR and ePrescription systems is 
the selection of the data processing equipment required in every area involved in the 
project. 
 
Some   recommendations   to   assess   the   vendor’s  proposals that may be interesting to 
take into account are outlined hereunder: 
- Amount and price of the new equipment: refers to the amount of new 
equipment needed for the new system and the value of their acquisition. 
- Installation requirements: Refers to the power requirements and lighting 
required for the new equipment. 
- Equipment performance: relates to the capabilities and both technical and 
operational characteristics as well as to the amount of data that can be 
processed in a specified period of time.  
- Support and assistance provider 
- Contract maintenance: refers to services for maintenance of equipment in 
good operation conditions.  
- Training: Relates to the offer of training programs to the personnel that will use 
the equipment in order to ensure a proper operation. 
- Other considerations: availability of the equipment (delivery time), availability 
of compatible equipment that could process data in an emergency, overtime 
costs, etc.  
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2.2.2. Implementation of the software 
Once the software for the systems and the necessary technological infrastructure have 
been acquired, it is possible to proceed with the implementation of the software in the 
hospital. In this project it is presented a progressive dissemination of the use of EHR 
and ePrescription systems based on three phases: 
 
First phase: Mechanization  of  patients’  admission 
This phase  aims  at  creating  and  updating  patient’s  records  with  basic  information  such  
as  name,  age  and  sex  in  order  to  obtain  general  or  specific  patient’s  lists.  In  this  way,  
there is an opportunity to improve both the patient care by facilitating and regulating 
their access to medical services as the organization of work planning by means of a 
rational distribution of time and professional activities. 
The clinical staff affected at this first stage is mainly the administrative and nursing 
personal. 
 
Second phase: Deployment of EMRs and ePrescribing at the medical consultations 
The objective of this phase is the introduction of Electronic Medical Records at 
physician’s   consultations   and   Electronic   Prescribing   at   both  physician’s   consultations  
and satellite pharmacies of the hospital. This way, on the one hand it is introduced the 
digitalization of all patient information; diagnosis and treatment plan (adding medical 
tests,  if  needed)  shaping  patient’s  personalized  records.  On  the  other  hand,  after  that,  
physicians open an electronic prescription according to the prescribed treatment plan, 
which is transmitted to the corresponding satellite pharmacy in order to trigger the 
pharmaceutical administration to the patient.  
The clinical staffs affected at this second stage are the administrative personal, nurses 
and physicians. 
 
Third phase: Dissemination of EMRs and ePrescriptions 
The aim of this phase is to integrate to the network other areas that may take 
advantage of these systems. For instance, implement or interlink the ePrescribing 
application to the Materials Management Department and the EMRs to the central 
pharmacy. 
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Forth phase: Deployment and dissemination of EPRs  
The scope of this phase is to integrate patients to the network as well by using EPRs.  
Healthcare providers should promote these systems and encourage patients to take 
part in the network. 
 
During the implementation process is very important to conduct training programs at 
each phase of the process to every area of the hospital and to the different clinical 
staff involved (at the forth phase, it is not necessary to conduct training programs to 
patients. Providing them with a clear Instructions Manual of how to use EPRs should 
be enough). This should go hand in hand with a monitoring program aiming at 
assessing the performance of users of the systems involved in the process and the 
systems themselves, and thus analyse their productivity. 
2.3. Renewal / Updating 
At last but not least, keeping the software up-to-date is the last step to guarantee a 
proper running and performance of the systems. 
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3. Conclusion 
The aim of this part of the thesis was to provide a general guideline on how to 
disseminate the use of EHRs by implementing EMRs and EPRs in one particular hospital 
in order to streamline the project of adopting EHRs nationally in Belgium. 
 
The roadmap proposed is based on three stages. At first, there is the preliminary 
definition phase, which aims at laying the foundations for the project by defining their 
aim, purpose and scope; studying its economical and financial feasibility; carrying out 
an accurate selection of the software provider; and finally establishing a baseline for 
the development of the project. Secondly, there is the process of implementing EMRs 
and EPRs, phase that include an action plan to provide the hospital with the 
technology   infrastructure   needed   as   well   as   set   the   basis   for   software’s  
implementation and adoption. Finally, the last phase can be seen as a reminder for the 
update of the system. 
 
The roadmap approach seeks to set a pathway to establish EHRs in hospitals by 
emphasizing the role to involve the stakeholders of the systems in the planning and 
project development. Their participation in the decision-making during the first phase 
plays an important role so enables to contribute to reduce possible future resistance 
to change of the users of the systems that may appear. Moreover, the importance of 
conducting training programs is also outlined. This will help to avoid inefficiencies that 
may arise during the implementation process due to a lack of knowledge of the 
functioning, operability and usability of the systems. This fact will be key factor to 
determine the future success of the implementation and adoption of the EHR system 
in a hospital. 
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Conclusions 
The main objective of this thesis was to analyse the impact of the digitalization of 
diverse processes and activities that take place in a hospital under the functionality of 
Electronic Health Record (EHR) systems upon the pharmaceutical supply chain of a 
hospital.   
The first two chapters of the thesis have focused on this aim. In the first one it was 
introduced the concept and found out the main reason of the increased adoption of 
Electronic Health Records (EHRs) in many hospitals around the world, which for 
Belgium, case of study, involved Electronic Medical Record (EMR), Electronic Patient 
Record (EPR) and Electronic Prescription (ePrescription) systems.  For the case of 
Belgium, it was found that many initiatives have been taken towards the 
implementation of EHRs at a regional and national level, the last one under the 
eHealth-platform proposal in 2008. Other initiatives around the adoption of these IT 
applications have been taken place internationally, such as in America, Australia or 
even at a European Union level with the Europe 2020 project launched by the 
European Commission. The main goal of all these initiatives is to promote 
interoperability, usability and health coordination between healthcare facilities at the 
different levels in order to improve the quality of care and cure of patients, allowing 
the free movement of patients, healthcare professionals and services.  
 
In the second chapter it was introduced the concept of hospital logistics, focusing the 
attention on the modus operandi of a hospital pharmaceutical supply chain. Then, an 
analysis of the management and inventory control for pharmaceuticals in hospitals 
before the introduction of EHR systems was provided. With the help of Porter's model, 
there were identified the main activities of the chain that generate value for the 
primary activity of a hospital: the care of patients. Afterwards, it was identified how 
the adoption of EHRs, by using ePrescriptions, may improve or add value to the logistic 
pharmaceutical chain of a hospital. It was concluded that the digitalization of 
information has a fundamental role since durability; legibility; completeness; and 
standardization of the records are improved in comparison with hand-written 
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prescriptions and paper-based drug charts. Furthermore, the use of EHRs not only 
improves the flow of data and information through the healthcare facility, which 
consequently may improve the traceability and efficiency of the hospital's physical 
flow, and between other stakeholders and institutions of the healthcare sector, but 
also the quality of information that can be stored and exchanged. This is due to the 
fact that an accurate recording, display, transmission and exchange of data and 
information are facilitated. As a result, these benefits have a positive impact on the 
pharmaceutical supply chain by improving pharmaceutical prescribing and dispensing 
workflow and supporting new ways of working and pharmaceutical management and 
inventory control policies in hospitals. Finally, in this second chapter was also arrived 
to the conclusion that the adoption of EHRs usage may have a beneficial impact on the 
hospital enterprise as well. All together, leads to a move away from product and 
process-centered towards patient-centered work, that is, an improvement of the 
quality of care delivered to patients, main concern of any hospital.   
As has been seen, logistics play a strategic role within a hospital. Its involvement goes 
beyond the simple transferring of supplies in response to the needs of patients and 
clinical staff; it has become a major stakeholder in developing solutions to the various 
logistics problems faced by a hospital and produce new organizational routines. 
Taking into account that the implementation of EHRs in Belgian hospitals is still at an 
early stage and considering the beneficial impact of EHRs in both the pharmaceutical 
supply chain and the main hospital enterprise, in the third chapter of this thesis was 
presented a roadmap to set the baseline to establish an EHR system in a hospital. 
 
To sum up, the adoption of EHRs is a good opportunity to improve business processes 
taking place within a hospital and at a highest level, adding value at the quality of care 
delivered to patients as well. 
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Further research  
In this thesis has been seen what the initiative behind the Europe 2020 project 
launched by the European Commission in the healthcare sector is. It has also been 
analysed the impact of this project in the pharmaceutical supply chain of a hospital 
and the main organization, and has been proposed a roadmap for implementation 
EHRs and ePrescriptions in hospitals trying to cope with barriers of implementation 
that take place in the current situation of Belgium. However, there is a need to further 
investigate on a barrier of adoption that is nowadays limiting the adoption of these 
systems in the country and has not been studied deeply in this project because of its 
complexity and lack of knowledge and information on the topic. That is, further 
investigation on the issues and disagreements regarding the privacy, security and 
confidentiality of these systems, as well as the existing political tensions that seem to 
exist between the Regional and Federal level of the country, in order to propose an 
action plan to combat this barrier. It would complement the study of this work. 
 
Moreover, there is a need to elaborate a progress evaluation tool for the roadmap 
proposed. That is, create a hospital performance measurement to assess the 
performance of the process of implementation and adoption of EHRs and 
ePrescriptions in the hospital. After that, it would be necessary to turn this roadmap 
into reality. That is, to carry out the process of implementing and adopting these 
systems and feed up the indicators set up with real data.   
 
As a last proposal for further research, how the data and information contained in EHR 
and ePrescription systems may improve and optimize the existing strategies or models 
for inventory control in hospitals may be a potential interest of study. 
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List of acronyms and abbreviations   
BCMA   Bar Code Medication Administration 
CPOE   Computerized Physician Order Entry 
DG SANTE  Director-General for Health and Food Safety 
DG INFSO   Director-General for Information Society and 
Media 
DMG   Dossier Médical Global 
DMI  Dossier Médical Informatisé 
EC  European Commission 
eHAP  eHealth Action Plan 
EHR  Electronic Health Records 
eMAR   Electronic Medication Administration Record 
EMR  Electronic Medical Record 
EPR  Electronic Patient Record 
ePrescription  Electronic Prescription 
FPS Social Security 
GP 
 Federal Public Service Social Security 
General Practitioner 
HIT   Health Information Technology 
ICT   Information and Communication Technology 
IT   Information Technology 
KCE   Belgian Health Care Knowledge Centre 
MTO   Make-to-order 
MTS  Make-to-stock 
NIHDI   National Institute for Health and Disability 
Insurance 
PCU   Patient Care Unit 
PHR 
RSW  
 Patient Health Record 
Réseau de Santé Wallon 
RFID   Radio Frequency IDentification 
RTD  Research and Technological Development 
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SUMEHR   Summarised Electronic Health Record 
WHO  World Health Organization 
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ANNEX 
Interviews to Mr. Bruno, Warehouse Manager at Hospital Logistics 
1st Interview: I am currently looking for information regarding the implementation of 
Electronic Health Records (EHR) and Electronic Prescriptions (ePrescritions) in Belgian 
hospitals. Do you have any experience with these systems? If not, may I have your 
opinion regarding this topic? 
 
No problem, it's always good to hear new ideas. But unfortunately I don't have any 
experience with ePrescriptions or Electronic Health records. But yes, I can give you my 
opinion on this and how I relate to this. 
 
I'm convinced that ePrescriptions can give the right transparency in the chain to 
decrease stock levels and still give the same high service level. I know this from my 
years in automotive. There it's standard to work with f.e EDI, I have a lot of experience 
in "in sequence" deliveries. The more information you get closer to the source where 
the need is created, the better. 
 
My experience with our customers (f.e UZ leuven, different other bigger hospitals in 
Belgium) is that hospitals are only now thinking to be more cost effective in general 
and cost effective with this kind of things. Only now because they are still receiving a 
big part of there budget from the government. So the need to be more cost effective 
isn't that high as say in the automotive. (f.e Edi is custom for more than 20 years in the 
automotive) 
 
But I can imagine a hospital pharmacy creating orders based on ePrescriptions. Very 
accurate info to base orders on. More accuracy, less "noise" in data, less stock needed 
(Bullwhip effect?). Nowadays, we deliver our orders based on the kanban principle or 
two-bin system.  
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2nd Interview: I am currently working on analysing inventory control and 
management in hospitals. Do you know the critera/models/strategies that hospitals 
follow to replenish inventory? Are they ordering purchases according to Multiperiod 
Inventory Models (such as Fixed-Order Quantity Model or Fixed-Time Period Model)? 
Perhaps, they also make orders on Bulk Ordering (with or without time-phase 
delivery)? 
 
I will try to explain it, as you noticed it's a complex process. 
 
We are owners of the stock. The main strategy that we use is min-max (variable 
quantity and period) strategy to create the orders to our suppliers. This is based on 
historical data of the last 3 months. Than we increase minimum stock when f.e 
supplier isn't reliable, supplier geographical location, peaks in demand, product 
changes, etc.  
 
Of course we take into account moq. And in other companies I used eoq. I like eoq as 
it's a robust formula. If you are 50% off it's still a good order qty. A difference that I 
always see is that I look at the stock in days and volume. As I need to monitor this for 
capacity in my warehouse. But my CEO looks at the stock in euros. It just needs to be a 
combination of the two.  
 
We do this for all of our articles. This is something that I tried to persuade my 
colleague (I'm not responsible for the actual calculation). I'm like the idea that I got 
from a book I have read.  
The idea is that you use different strategies for fast, middle and slow movers.  
- Fast movers: variable qty and variable period  
- Middle movers: variable qty and fixed period  
- Slow movers: frame orders. Big orders in one time. Less effort and management.  
 
I don't know if you can read Dutch. The book that I mentioned is a great practical book. 
You can download it, here is the link: www.durlinger.nl/files/boeken/Effectief-
voorraadbeheer.pdf  
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ANNEX I: 2004 e-Health Action Plan: Overview of actions 
Action 
NB. Within each of the issues facing the e-Health 
sector (addressing common challenges, pilot actions, 
and working together and monitoring practices), we 
list the actions to be taken sequentially. 
Time Responsibility 
   
Issue 1: Addressing common challenges 
The Communication on patient mobility is presented 
as part of an overall strategy on health care together 
with the present communication and that on the open 
method of coordination. 
Work is already underway to improve information on 
patient mobility and mobility of health professionals at 
European level, and is being taken forward in 
particular through the health systems working party 
under the information strand of the public health 
programme. 
2004 Commission 
By mid 2005, the Commission should produce a 
summary of European best practices as guidance for 
Member States. 
Mid-2005 Commission 
By end 2005, each Member State is to develop a 
national or regional roadmap for e-Health. This should 
focus on deploying e-Health systems, setting targets 
for interoperability and the use of electronic health 
records, and address issues such as the 
reimbursement of e-Health services. 
End 2005 Member States 
By end 2006, Member States, in collaboration with the 
European Commission, should identify a common 
approach to patient identifiers. This should take 
account of best practices and developments in areas 
such as the European Health Insurance Card and 
identity management for European citizens. 
End 2006 
Member States, 
Commission 
By end 2006, Member States, in collaboration with the 
European Commission, should identify and outline 
interoperability standards for health data messages 
End 2006 
Member States, 
Commission 
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and electronic health records, taking into account best 
practices and relevant standardisation efforts. 
By end 2006, a collaborative approach should be 
undertaken among Member States to supporting and 
boosting investment in e-Health. 
End 2006 Member States 
By end 2007, Member States should adopt conformity 
testing and accreditation schemes following successful 
best practices. 
End 2007 Member States 
During the period 2004-2008, Member States should 
support deployment of health information networks 
for e- Health based on fixed and wireless broadband 
and mobile infrastructures and Grid technologies. 
2004-
2008 
Member States 
By end 2009, the European Commission, in 
collaboration with Member States, should undertake 
activities to: 
Set a baseline for a standardised European 
qualification for e-Health services in clinical and 
administrative settings. 
Provide framework for greater legal certainty of e-
Health products and services liability within the 
context of existing product liability legislation. 
Improve information for patients, health insurance 
schemes and providers regarding the rules applying to 
the assumption of the costs of e-Health services. 
Promote e-Health with a view to reducing 
occupational accidents and illnesses as well as 
supporting preventive actions in the face of the 
emergence of new workplace risks. 
End 2009 
Commission, 
Member States 
Issue 2: Pilot actions: accelerating beneficial 
implementation 
By end 2005, a European Union public health portal 
will give access to European level public health 
information. Health portals shall offer dedicated 
information on safety at work and health risks in the 
End 2005 Commission 
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workplace. 
By end 2005, there will be a strengthening of early 
warning, detection, and surveillance of health threats 
through enhanced information and communication 
technologies tools. 
Promoting the use of cards in the health care sector. 
Adoption of implementation of an electronic health 
insurance card by 2008. 
2008 
Commission, 
Member States 
By end 2008, the majority of European health 
organisations and health regions (communities, 
counties, districts) should be able to provide online 
services such as teleconsultation (second medical 
opinion), e-prescription, e-referral, telemonitoring and 
telecare. 
End 2008 Member States 
Issue 3: Working together and monitoring practices 
In 2004, a high-level e-Health forum should be 
established, the role of which will be to support the 
Commission services. It should involve all necessary 
stakeholders, including at national, regional, or local 
hospital authority levels, thereby enhancing the 
understanding of the Commission services with regard 
to the current and planned status of development of 
e-Health in Member States. Its task should be to follow 
up the various roadmaps, and to identify further 
actions including a strong focus on users and access 
for all to e-Health, as well as to develop a strong 
evidence basis for the case for e-Health. The work of 
the e-Health forum will also be closely associated with 
the implementation of the Community Public Health 
Programme. 
2004 Commission 
By the start of 2005, Member States, in collaboration 
with the European Commission, should agree on an 
overall approach to benchmarking in order to assess 
the quantitative, including economic, and qualitative 
impacts of e-Health. 
Start 
2005 
Member States, 
Commission 
By the end of 2005, the European Commission, with End 2005 Member States 
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contributions from Member States, should establish an 
effective way of disseminating best practices and 
supporting actions within the European e-Health area. 
An assessment of e-Health developments should be 
completed ahead of the second part of the World 
Summit to be held in Tunis in 2005. 
2005 
Commission, 
Member States 
During the period 2004-2008, Member States with the 
support of the European Commission will organise 
special events such as high level conferences in order 
to disseminate best practices. 
2004- 
2008 
 
Member States, 
Commission 
During the period 2004-2010, every two years, the 
European Commission will publish a study on the state 
of the art in deployment, examples of best practices, 
and the associated benefits of e-Health. 
2004 -
2010 
Commission 
Table 4 Overview of the actions in the 2004 e-Health Action Plan (Liikanen, 2004, pp. 23-26) 
 90 
ANNEX II: Organization of the Health system in Belgium 
In 2010, The European Observatory on Health Systems and Policies has, in 
collaboration with the KCE (Belgian Health Care Knowledge Centre), published its latest 
version   of   a   series   of   reports   entitled   “Health   In   Transition”   for   Belgium. As this 
publication provides a detailed description of Belgian health system and of reform and 
policy initiatives in progress or under development in the country, is going to serve as 
a main basis for this section.  
So as to give some perspective to the organizational structure of the Belgian health 
sector, it is useful to first note the general political structure of Belgium.  
“Belgium   is  a   federal   state  with  a  parliamentary  democracy.  There  are  
three levels of government – the federal government, the federated 
entities (three regions [based on territory: the Flemish, the Walloon and 
the Brussels-Capital regions] and three communities [based on language 
and culture: Flemish, French and German communities) and the local 
governments (provinces and municipalities).” (Gerkens and Merkur, 
2010, p.29)  
Due to the fact that there are both French and Dutch speaking individuals living in the 
Brussels-Capital region, three institutions were created so as to enable community 
specific policies to be conducted in the region: the French Community Commission 
(COCOF), the Flemish Community Commission (VGC) and the Joint Community 
Commission (GGC-COCOM).  
There  is  a  “repartition  of  competences  between  these three levels of power (federal, 
federated  and  local  authorities)” (Gerkens and Merkur, 2010, p.40).  
As far as the Health system in Belgium is concerned, its responsibilities for healthcare 
policy are shared between the federal state and the communities. The three regions 
handle territorial matters while the health care responsibilities of the provinces and 
municipalities are limited, based on general advisory functions.  
“The   federal   level   is   responsible   for   the   regulation   and   financing   of  
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compulsory health insurance; the determination of accreditation criteria 
(that is, minimum standards for the running of hospital services); the 
financing of hospital budgets and   heavy   medical   equipment   (…);  
legislation covering different professional qualifications; and the 
registration of pharmaceuticals and their price control. At the level of 
federated entities (regions and communities), governments are 
responsible for health promotion and prevention; maternity and child 
health services; different aspects of elderly care, home care, 
coordination and collaboration in primary health care and palliative 
care; the implementation of accreditation standards and the 
determination of additional accreditation criteria; and the financing of 
hospital investment. To facilitate cooperation between the federal level 
and governments of regions and communities, interministerial 
conferences  are  regularly  organized).” (Gerkens and Merkur, 2010, p.48) 
The figure below shows a general schema of Belgian Health system organization at the 
federal level and the level of federates entities, with the most important departments, 
agency and advisory bodies. 
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Table 5 Organization of the Belgian healthcare system (Gerkens and Merkur, 2010, p.25) 
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Below, it is defined the overall objective of each entity represented in the above 
scheme. 
FEDERAL LEVEL 
“At   the   federal   level,   the  parliament   is   the   legislative  body.   The   federal government 
and  the  Minister  of  Social  Affairs  and  Public  Health  are  the  executive  bodies” (Gerkens 
and Merkur, 2010, p.56). The main federal departments, agencies and advisory bodies 
are described as follows. 
Entities of organization and financing activities: 
The FPS Health, Food Chain Safety and Environment 
It consists of four departments: 
- Health  Care  Facilities  Organization:  it  is  “in  charge  of  the  organization,  planning  
rules, recognition criteria, evaluation of the quality of medical and nursing 
practices in health care facilities, registration of data and financing of inpatient 
health   care   facilities,   as   well   as   the   implementation   of   patients’   rights” 
(Gerkens and Merkur, 2010, p.58). 
- Primary Health Care and Crisis Management: its responsibilities   include   “the  
recognition and planning of activities for health care professionals, and 
designing a policy for the prevention and monitoring of health crisis, including 
crisis scenarios, emergency plans   and   organization   of   relief” (Gerkens and 
Merkur, 2010, p.59). Apart from that, the department is responsible for the 
organization of emergency medical assistance, as well. 
- Animal, Plant and Foodstuffs:   it   is   “responsible   for   policies,   notification,  
standardization and inspection in the domains of food, food chain safety, 
alcohol,  tobacco,  cosmetics  and  pesticides” (Gerkens and Merkur, 2010, p.59). 
- Environment:  department  “responsible  for  matters  concerning  climate  change,  
biodiversity and genetically modified organisms, marine environment, chemical 
substances,   electromagnetic   fields,   product’s   inspection   and   environmental  
rights” (Gerkens and Merkur, 2010, p.59). 
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The FPS Social Security 
This   entity   “sits   at   the   crossroads   of   all   legislation   that   contributes   to   the   social  
security  of  citizens”.  It  ensures that  everybody  “appropriately enjoys social rights and 
aims to ensure the viability of a system of support and solidarity that is as efficient as it 
is  fair” (Gerkens and Merkur, 2010, p.59). 
National Institute for Health and Disability Insurance (NIHDI) 
The NIHDI has a series of important tasks due to it is   “responsible   for   the   general  
organization and financial management of the compulsory health care and benefits 
insurance” (Gerkens and Merkur, 2010, p.60). It is composed of five departments: 
- Health Care  Department:   it   is   “charged  with   the   administrative   and   financial  
management of compulsory   health   insurance” (Gerkens and Merkur, 2010, 
p.60). 
- Department   for   Medical   Evaluation   and   Inspection:   it   aims   to   inform   “the  
health care providers about the correct application of the health care and 
benefits insurance regulation, more specifically to prevent administrative 
errors” (Gerkens and Merkur, 2010, p.60). 
- Benefits   Department:   it   is   in   charge   of   “determining   criteria   and   guidelines  
concerning benefits in case of incapacity for work, and in case of maternity, 
paternity  or  adoption  leave” (Gerkens and Merkur, 2010, p.60). 
- Department   for   Administrative   Inspection:   it   is   “responsible   for   monitoring  
legal and other regulations of the sickness funds (…)   also   in   charge   of  
sanctioning non-adherence  to  the  rules” (Gerkens and Merkur, 2010, p.60). 
- General Support Departments:   it   offers   “”strategic”   support   to   the   other  
departments of the NIHDI (human resources management, ICT support, etc.). 
National Social Security Office (NSSO) 
The mission of the NSSO   is   the   “central   institution   in   the   social   security   system   for  
private sector employees  and  most  civil  servants” (Gerkens and Merkur, 2010, p.59). 
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The Federal Agency for Medicines and Health Products 
It aims to ensure the quality, safety and effectiveness of pharmaceuticals for humans 
and animals. 
Sickness funds 
The overall purpose of this entity is to provide insurance to the sickness funds as well 
as being in charge of medical auditing.  “Sickness  funds  are private non-profit-making 
organizations  with  a  public   interest  mission” (Gerkens and Merkur, 2010, p.64). They 
are active members of both the executive and the advisory committees of the NIHDI, 
from whom receive their financial resources. 
The Supervising Authority for Sickness Funds and National Associations of Sickness 
Funds 
“General   control   over   the   sickness   funds   and   the   national   associations   of   sickness  
funds” (Gerkens and Merkur, 2010, p.64) is exercised by this entity. This way, it is 
ensured that the services and activities established by the sickness funds and their 
associations are in agreement with the Sickness Funds Act and, moreover, that 
administrative, accounting and financial regulation is respected. Apart from that, it 
aims to evaluate the management performance of the sickness funds. 
The Federal Agency for Nuclear Control 
Its   purpose   is   to   “ensure   that   the   population   and   the   environment   are   effectively  
protected against the dangers  of  ionizing  radiation.” (Gerkens and Merkur, 2010, p.64) 
Consultative bodies: 
Scientific Institute of Public Health (IPH) 
The mission of the IPH is to provide the federal and federated government with 
knowledge, based on scientific evidence, of health promotion and disease prevention. 
Its main activities “consists   of   four   operational   directions:   communicable   and  
infectious diseases; food, medicines and consumer safety; public health and 
surveillance; and expertise, service provision and customer relations.” (Gerkens and 
Merkur, 2010, p.65) 
 96 
National Council for Hospital Facilities 
This  entity  “plays  an   important  role   in  the  formation  of  Belgian  health  care  policy  by  
advising the Minister of Social Affairs and Public Health on issues related to hospital 
planning,  accreditation  and  financing” (Gerkens and Merkur, 2010, p.65). 
Multipartite consultation structure for hospital policy 
“The   goal   of   this   consultative   structure   is   to   build   bridges   between   the   NIHDI  
(providing insurance for inpatient care) and the FPS Health, Food Chain Safety and 
Environment (responsible for the organization and quality regulation of inpatient care) 
to improve administration  in  the  hospital  sector).” (Gerkens and Merkur, 2010, p.65) 
Belgian Health Care Knowledge Centre (KCE) 
The KCE provides scientific support to health care decision-makers. Working together 
with all main stakeholders in the health care sector, the entity 
“is   active   in   producing   recommendations   and   carrying   out   research   in  
the following areas: the analysis of clinical practice and the 
development of guidelines for Good Clinical Practice (Good Clinical 
Practice); the assessment of medical technology and medicine (health 
technology assessment (HTA)); and the study of health care organization 
and financing (Health Services Research, including research on equity 
and  patient  behaviour).” (Gerkens and Merkur, 2010, p.66) 
Superior Health Council 
It   aims   to   link   government  policy   and   scientific   community   in  public   health   field.   “It  
deals mostly with the following areas: mental   health   (…),   physical   and   chemical  
environment  (…),  nutrition  (…),  and  biological  problems” (Gerkens and Merkur, 2010, 
p.65). 
National Council of Nursing 
The mission of this entity is to provide advice and recommendations to the Minister of 
Social Affairs   and   Public   Health   on   “all   matters   relating   to   the   art   of   nursing   and  
particularly on the practice of nursing   and   required   qualifications” (Gerkens and 
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Merkur, 2010, p.67). 
FEDERATED LEVEL 
Flemish Community 
For   the  Flemish  community,  “the  Flemish  Agency for Care and Health of the Flemish 
Ministry of Welfare, Public Health and Family is responsible for the development, 
implementation and evaluation of policies concerning regional health and care 
responsibilities.” (Gerkens and Merkur, 2010, p.67) 
French Community 
For  the  French  community,  “public  health  policies  are  administered  by  the  Directorate-
General of Health within the Ministry of the French Community” (Gerkens and Merkur, 
2010, p.68). Moreover, the Birth and Childhood Organization Office (ONE) and the 
Superior Council of Health Promotion are agencies involved in public health policy in 
the French community as well.  
However,   some  of   the   community’s   responsibilities  were   transferred   to   the  Walloon  
region.   For   example,   a   “regional  Health  Observatory was also set up in the Walloon 
region   to   improve   health   in   the   region   and   to   contribute   to   health   information” 
(Gerkens and Merkur, 2010, p.68).  
German-speaking Community 
For the German-speaking community, it is the Department of Cultural and Social 
Affairs of the Ministry of the German-speaking   Community   that   “is   responsible   for  
matters related to public health  and  health  promotion.” (Gerkens and Merkur, 2010, 
p.69) 
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ANNEX III: List of SUMEHR contents 
SUMEHR contents 
Date of creation  
Author  
Patient identification  
Patient presentation * Family name 
 * Forenames 
 * Sex 
 * Birth date 
 * Usual language 
Contact person  
Risks * Allergies 
 * Adverse drug reactions 
 * Social factors 
 * Other factors 
Relevant personal 
antecedents 
* Standardisation: IBUI and ICPC-2 and ICD10 
 * Begin date 
 * Text 
Relevant medications * CNK (Code National(e) Kode) or other Id (if no 
available CNK) 
 * Administration information 
 * Instructions for patient 
 * Begin date  
 * End date 
 * Text 
Vaccination status * Administrated 
x CNK and/or ATC (Anatomical 
Therapeutic Chemical-code 
x Date 
 * To be administrated 
x CNK and/or ATC 
x Date 
Table 6 List of SUMEHR contents (Devlies et al., 2010, pp.39-40) 
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ANNEX IV: Legal and regulatory facilitators 
Legislation on medical Records 
In Belgium, over 225 medical record related Royal Decrees have been issued, between 
January 1st 1999 and October 31st 2008. 25 of these were specifically dedicated to the 
“electronic  medical  record”.  The  official  start  of  dealing with the contents of electronic 
medical  records  was  marked  by  the  Law  on  “Social  Affairs”  in  19994, empowering the 
king to define minimal (quality/functional) criteria to medical / healthcare software in 
order to be homologated by the Ministry of Health. This law article applies to medical 
records as well as to nursing records. Another important piece of legislation regarding 
eHealth was the Royal Decree (KB/AR) of May 3rd, 1999, which created the 
commission   for  „Norms  related  to   telematics   in  support   of   the  healthcare   sector.“  A  
decree of the same date also defined the minimal content of a Hospital Medical 
Record, and was completed by the Royal Decree (KB/AR) of April 16th, 2002. 
Legislation on ID Cards 
Legislation which helped prepare national identification registers and cards includes 
the law of 25th March 2003 on the legal framework of electronic ID cards. It modified 
the law of 8th August 1983 (organising a national registry of physical persons) and the 
law of 19th July 1991 (on population registers and identity cards). Additional 
specifications on the topic were provided by the Ministerial Decree of 26th March                                                         
4 Law  on  “Social  Affairs”  of  January  25th, 1999 RD (KB/AR), adding an Article 45 to the 
KB/AR 78. In addition, the Royal Decree (KB/AR) of 3rd May 1999 defined the minimal 
content of a Hospital Medical Record, and was completed by the Royal Decree (KB/AR) 
of 16th April 2002. Such a record is to contain the following information: Identity of the 
patient; Personal Health History; Family Health History; Actual Diseases or Problems or 
Health Issues; Data about / from previous patient contacts and hospitalisations; 
Results of clinical, imaging, lab, functional and histo-pathological test; Reports / 
advices from consulted health care professionals; Provisional and/or final diagnosis for 
the  actual  stay;  Treatment.  For  surgical  treatments  (16  April  2002):  the  intervention’s  
and   anaesthetist’s   report;   Evolution   of   the   affection;   If   applicable   the   report   of   the  
autopsy;   Copy   of   the   discharge   letter;   Specific   data   regarding   the   use   of   “blood  
products”. 
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2003 on the format of electronic ID cards, the Royal Decree of 1st September 2004 on 
the generalisation of electronic ID cards, and the Royal decree of 18th October 2006 
on the eID document for Belgian children under 12.5 Furthermore, the legislation on 
the electronic signature from 17th March 2003 defined certain legal aspects of 
information society services. 
There is no specific law regarding telemedicine services. In this field, so far the general 
legal rules regarding care provision and privacy protection apply. 
Patient rights 
Patient rights, which are here mainly described in relation to medical records, are 
derived from two Belgian legislative sources: the Privacy Legislation (Law of 8th 
December 1992, published 18th March 1993, enacted regarding the processing of 
personal data by the Royal Decree of 13th February 2001, published on the same day6) 
and the law on patient rights7. Patient rights legislation has been adopted since 22nd 
August 2002, (publication 26th September 2002)8. 
                                                        
5 European Communities 2007 
6 On 11th December 1998, the Privacy Act was adapted to the European Directive 
95/46/EC. The transposition of this directive into Belgian law led to fundamental 
changes in the Privacy Act, making a new implementing decree necessary. This Royal 
Decree lays down: 
-  the conditions authorizing the further processing of personal data for historical, 
statistical or scientific purposes;  
-  the conditions for processing sensitive data;  
-  the way in which a person whose data are processed may exercise his rights (access, 
rectification, deletion of his data);  
-  the   way   in   which   the   automatic   processing   of   personal   data   has   to   be   notified.”  
 Commission for the protection of privacy, 
http://www.privacycommission.be/en/legislation/national  
7 Centre for Biomedical Ethics and Law of the Catholic University of Leuven 
8 In Belgium, there is a difference between the date of adoption of a law and the date 
of the publication of the law. A law applies at earliest when published in the official 
Journal. But usually, when indicating a specific the date of adoption is used.  
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Opting-in model for medical records 
Patient rights legislation with relevance to the creation of electronic patient records in 
Belgium prescribes the opting-in model. This means that by law explicit consent is 
required (except in emergency medicine). However, the forms in which consent can be 
given are not clearly defined. It does not always have to be in written form. Consent 
can be implicit if the treating physician can reasonably derive consent from the 
behaviour of the patient (e.g. patients presenting themselves for a diagnosis and/or 
treatment). The collection of the data has to be fully in line with the privacy protection 
legislation of natural persons. 
Data Access rights for patients 
Citizens have a right to be informed of the information contained in their medical 
records. The information provided has to be clear. However, the patients can also 
exert their right "not to know" and the physician in charge can invoke "therapeutic 
exception rules" if he/she thinks that providing the information is detrimental for the 
patient. Both, patient or treating physician, can decide to involve a trustworthy "go-
between" or a custodian. In that case, therapeutic exception can be waved in favour of 
the custodian. Personal notes made by the physician remain personal and do not have 
to be communicated, though the legal definition of "personal notes" is not clear. 
Generally, the patient has read-only access to his/her patient record. However, 
according to patient rights legislation patients can demand that "documents" be 
attached to their medical record, but neither is the sort of document specified, nor is 
there any provision for patients making any additions themselves. Likewise, the 
patient cannot directly delete data, but he/she can demand deletion of data, hide 
certain types of information and bar certain healthcare providers from access to the 
healthcare record. According to privacy legislation, a citizen can either demand the 
correction, removal or forbid the use of personal data that is incorrect, incomplete, 
not fit for the purpose or unlawfully collected or kept (e.g. after expiry of the recording 
period). These rights are not mentioned in the legislation on patient rights. The patient 
keeps the right to withdraw his/her consent. Emergency medicine is in the first 
instance governed by the penal code (art 422bis) where life threatening situations are 
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dealt with, often in a context without recurrence to consent or preferences of the 
patient and with insufficient time to contact a third party on his behalf. 
Data Access for patient representatives 
A third party, for example parents or other family members or any other person 
related to the patient, cannot gain access to personal data without consent of the data 
subject, unless they have legal custody on the data subject (e.g. in case of minors or 
mentally handicapped persons). According to patient rights legislation, a citizen can 
consent and even demand that a trustworthy person has access to his medical 
personal data on this behalf. In the case of therapeutic exception, the treating 
physician can even propose this initiative himself. 
Secondary data use 
Secondary use of (patient) data is possible, provided that the rules in the Belgian 
legislation (which is an instantiation of the EU data protection directive) are followed. 
If personal health data are concerned, explicit patient consent is required in all cases 
where it can be obtained. 
(Good guidelines are available at the website of the Belgian Data Registrar9. There are 
recommendations that whenever possible totally anonymous data should be used, if 
not, encoded (i.e. de-identified) data should be used. In a very last instance and under 
strict conditions, personal data can be used.) 
 
 
 
 
 
 
 
                                                         
9 Commission for the protection of privacy 
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ANNEX V: Impact of logistics on the cost structure of a hospital 
 
 
  
Clinical staff 40%  
Personal auxiliary 20% 
Supplies and equipment 27%  
Others 13%  
Salary costs Non-salary costs 
- Specialities - Surgical Block - Emergencies - Intensive Care - Radiology - Laboratories… - …  10% 
- Sterilization - Purchasing - Accounting - Administration - RRHH - Warehouse - …  75% 
- Consumables - Drugs - Food - Equipment - Investments - …   100% 
- Insurance - Immobilizations  - …      0% 
4% 15% 27% 
46% 
Figure 9 Impact of logistics on the costs structure of a hospital (Adapted from Chow and Heaver, 1994) 
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ANNEX VI: Classification systems for materials 
The following table presents different types of selective controls, their basis and their 
use. 
Type of Control Basis Main Use 
ABC Value of consumption of item Control inventory value 
HML Unit price of item Control purchases 
XYZ Value of items in store Review inventories 
VED Criticality of item Inventory control of spares 
FSN Consumption pattern of item Control obsolescence 
SDE Problems of procurement 
Lead time analysis and purchasing 
strategies 
GOLF Source of supply Procurement strategies 
SOS Nature of supply 
Procurement and holding strategies 
for seasonal items 
Table 4 Types of Selective Controls (Reddy, 2008) 
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